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ABSTRACT
Speaker, Elizabeth, M.S., December 2010

Health and Human Performances

Evaluation of an HIV and HCV Prevention Intervention: Taking it to Treatment Court
Chairperson: Annie Sondag
The purpose of this study was to evaluate the HIV/HCV prevention intervention, Taking
it to Treatment Court (TITTC), which is part of the greater Yellowstone County Family
Drug Treatment Court (YCFDTC) program. The findings from this study will be used by
the Montana Department of Public Health and Human Services, The Yellowstone County
Family Drug Treatment Court, and the Montana HIV Prevention Community Planning
Group to determine the effectiveness of TITTC and make changes as necessary. To
evaluate TITTC this study utilized quantitative and qualitative research methods.
Quantitative data were collected through a Theory of Planned Behavior survey and an
HIV and HCV knowledge questionnaire. Participants of TITTC were given the survey
instrument pre intervention, two weeks post intervention, and again at a three month
follow up. Urinalysis and arrest report data were also collected from YCFDTC and
compared to self report data. Qualitative data were collected through two focus groups
with past participants of TITTC. Results of this study indicate that the TITTC
intervention was effective in increasing participants’ HCV knowledge; increasing overall
intentions to abstain from drug use, and improving attitudes towards abstaining from drug
use. The intervention also was successful at encouraging participants to test for HCV.
The intervention did not result in significant gains in HIV knowledge nor in intentions to
practice safer sex. In addition, results also revealed a lack of congruence between self
reported drug use and the urinalysis and arrest data. Emergent themes from the focus
group data validated findings from the survey data. Overall, TITTC appears to have
some positive effects on participants’ intentions to engage in HIV and HCV risk
reduction behaviors. Evaluators recommend that the program be lengthened and that
facilitators spend more time on the areas where fewer gains were seen. Given the
preliminary success of the program, expanding TITTC to other drug courts throughout
the state of Montana is advised.
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Chapter I
Introduction

Drug court rose out of Dade County, Florida in 1989 as a response to jails becoming
overcrowded with individuals on non-violent drug charges. The drug court model was the
first attempt to rehabilitate drug offenders utilizing a combination of the criminal justice
system, social services, counseling, and life training skills (Huddleston, Freeman-Wilson,
& Boone, 2004). The purpose of drug courts is to reduce recidivism and substance abuse
rates among nonviolent substance abusing offenders and “increase the offenders’
likelihood of successful habilitation through early, continuous, and intense judicially
supervised treatment, mandatory periodic drug testing, community supervision and use of
appropriate sanctions and other habilitation services” (Huddleston et al., 2004). The
National Survey on Drug Use and Health estimated there were 19.9 million illicit drug
users aged 12 and older (DPHHS, 2008), so it is not surprising widespread adoption of
the drug court model has occurred throughout the United States and is appearing
internationally as well. As of December 31, 2007 there were 2,147 drug courts operating
in the United States, and this number continues to grow every year (Huddleston,
Marlowe, & Casebolt, 2008). Many new drug court models have specific population
targets such as adults or juveniles only, families, universities, tribes or drunk driving
(Huddleston et al., 2004).
Family drug treatment courts first appeared in Reno, Nevada in 1995. This
system utilized the traditional drug court model, but narrowed the focus to drug abusing
parents charged with child abuse or neglect, in a civil rather than criminal court system.
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Family drug court was designed to address findings suggesting that 80% of child abuse
cases involved parents who had a substance abuse problem (Huddleston et al., 2008).
The ultimate goal is timely resolution of the child maltreatment cases for the benefit of
children, families and society (Roche, 2008). As of December 31, 2007 there were 301
family drug courts in operation, and four of those were located in Montana (Huddleston
et al., 2008).
Yellowstone County Family Drug Treatment Court (YCFDTC) is one of the
family drug court systems in Montana. The focus of this study was on YCFDTC’s
human immunodeficiency virus (HIV) and hepatitis C (HCV) prevention intervention
Taking it to Treatment Court (TITTC) in Billings, MT. Specifically, the study examined
TITTC’s effectiveness to promote factors that enhance participants’ intentions to practice
HIV and HCV risk reduction behaviors – in particular the practice of safer sex and
abstinence from drug use.
Injection drug use (IDU) is the most common route of exposure for HCV and
second most common route for HIV (CDC: Basic Statistics, 2008; CDC: MTDPHHS,
2008). HIV is the virus that causes acquired immunodeficiency syndrome (AIDS) which
impairs immune function, ultimately leading to death (CDC, 2006). There are
approximately 1.1 million people living with HIV/AIDS in the United States. In 2006
there were 56,300 new cases of HIV diagnosed (CDC, 2008). Practicing unsafe sex,
vaginally or anally, is the most common route of exposure for HIV infection. Men who
have sex with men (MSM) are the highest risk group for HIV (CDC: Basic Statistics,
2008). While injection drug use is not the most common route of exposure to HIV, it
does contribute to infection rates indicating more prevention and awareness efforts are
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needed within this population. Injection drug use has accounted for 36% of all reported
HIV cases in the US since the epidemic began (CDC, 2002).
As of February 17, 2010, there were 955 reported cases of HIV in Montana since
1985; of those reported cases, 445 are living cases. Injection drug use accounts for 13%
of the reported cases of HIV in Montana (MT-DPHHS, 2009). In February 2009 there
were 122 known living cases of HIV related to injection drug use in Montana, with 33
percent, or 40 of those cases in Yellowstone County (MT-DPHHS, 2009).
HIV positive people who use injection drugs frequently are co-infected with
HCV. Studies funded by the National Institute on Drug Abuse (2008) have found that
within three years of injection drug use, most injection drug users will contract HCV, and
upwards of 90% of HIV infected persons who use injection drugs may also be infected
with HCV. Hepatitis C (HCV) is a viral infection of the liver transmitted through
contaminated blood which can lead to cirrhosis and liver cancer in chronic cases (CDC:
Hepatitis C, 2008). HCV is the most common chronic blood borne infection in the
United States, and the most common route of exposure is injection drug use (Shepard,
Finelli, & Alter, 2005). The United States is estimated to have 3.2 million people
chronically infected with HCV, with an estimated 30,000 new cases each year (CDC:
Hepatitis C, 2008). Of those new cases, approximately 68% are attributable to IDU
(Shepard et al., 2005).
Prevention strategies remain crucial to slow the spread of HIV and HCV infection
amongst persons who use injection drugs since there is no cure or vaccination for either
virus (CDC, 2006; WHO 2000). Prevention strategies focus on education and harm
reduction methods such as community outreach, methadone treatment, needle exchange,
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and in-patient or out-patient abstinence programs (Coyle, Needle, & Normand, 1998).
Community outreach strategies, such as face-to-face communication; HIV awareness,
prevention, and available services; condom distribution; bleach kit distribution for
cleaning injection equipment; information on available drug treatment options within the
community; and HIV testing and confidential risk assessments, have been identified as
one of the top three prevention strategies for reducing incidence of HIV among IDUs
(Coyle et al., 1998). Providing sterile injection equipment and providing education on
safer injection practices remain the primary methods to reduce HCV incidence (Edlin,
2002). While disease transmission rates have gone down in the presence of prevention
efforts, HCV rates remain high compared to HIV rates amongst persons who use
injection drugs. Hepatitis C transmission is approximately ten times more efficient than
HIV (Edlin et al., 2005) indicating prevention efforts need to be directed at more than just
using sterile syringes.
Taking it to Treatment Court (TITTC) is the only intervention program within the
YCFDTC system to offer clients information on HIV and HCV risk reduction behaviors.
This intervention also provides YCFDTC participants the opportunity to enhance their
education and awareness of HIV and HCV, build a support system, and receive one-onone mentoring. After completion of the six hour course, a graduation ceremony is held
one week later, open to friends and family. Participants are given the opportunity to
discuss what they learned from TITTC. The final stage of TITTC consists of two
individual follow up sessions with the group facilitator over a two month period where
participants can seek more individualized care and referrals as needed.

Participants of

TITTC are encouraged to take advantage of the follow up services upon release from the
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YCFDTC. Some of these services include family support, job and housing referrals,
street outreach, further HIV/HCV counseling, parole planning, and harm reduction
counseling (Roche, 2008). Follow-up services are coordinated by the outreach workers
who facilitate TITTC.

Purpose of the Study
The purpose of this study was to evaluate the HIV/HCV prevention intervention, Taking
it to Treatment Court. This evaluation examined whether the program (1) increased
participants’ knowledge about HIV/HCV risk reduction behaviors and (2) if their
attitudes and beliefs about safer sex and drug use were affected. The findings from this
study will be used by the Montana Department of Public Health and Human Services,
The Yellowstone County Family Drug Treatment Court, and the Montana HIV
Prevention Community Planning Group to determine the effectiveness of TITTC. If
found effective at increasing participants’ knowledge about HIV and HCV and their
intentions to change risk behaviors associated with HIV and HCV, TITTC may be
expanded to all family drug treatment courts in Montana.

Statement of the Problem
Injection Drug Use (IDU) is the leading risk factor for HCV in the United States
today (CDC: Hepatitis C, 2008). As of December 31, 2008 there were 9,593 known
cases of HCV in Montana. It is estimated 20 to 40 percent of those cases are related to
IDU, or 1,919 to 3,837 cases respectively (Baus: CDC, 2009). The use of injection drugs
is a major risk factor for HIV as well. In February 2009 there were 122 known living
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cases of HIV related to injection drug use in Montana with 33 percent, or 40 of those
cases, in Yellowstone County (MT-DPHHS 2009). Preliminary data from the Montana
Department of Public Health and Human Services (2008) estimates 93 known living
cases of HIV and HCV co-infection in Montana with injection drug use as the primary
risk factor.

Research Questions
Research questions for this study focused on the effect Taking it to Treatment Court had
on YCFDTC clients’ knowledge, attitudes, beliefs, subjective norm, and control factors
pertaining to HIV and HCV risk reduction behaviors. For the purpose of this study, risk
reduction behaviors were defined as abstinence from drug use and safer sex practices
through condom use. The questions were as follows:

Hypothesis 1
Intervention participants will demonstrate a significant gain in mean knowledge scores on
The HIV Knowledge Questionnaire between pretest and a two week post test.
1a: These gains will be maintained at a three month follow-up post test.

Hypothesis 2
Intervention participants will demonstrate a significant gain in mean knowledge scores on
The HCV Knowledge Questionnaire between pretest and a two week follow-up post test.
2a: These gains will be maintained at a three month follow-up post test.
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Hypothesis 3
Intervention participants will demonstrate significant gains in intention to practice safer
sex as demonstrated by scores on the Theory of Planned Behavior Questionnaire between
pretest and a two week post test in the following areas:
a) positive attitude toward condom use
b) positive subjective norm toward condom use
c) positive control beliefs regarding condom use
3a: These gains will be maintained or further improve at the three month follow-up post
test.

Hypothesis 4
Intervention participants will demonstrate significant gains in intention to abstain from
drug use as demonstrated by scores on the Theory of Planned Behavior Questionnaire
between pretest and a two week follow-up posttest in the following areas:
a) positive attitude toward abstaining from drug use
b) positive subjective norm toward abstaining from drug use
c) positive control beliefs regarding abstinence from drug use
4a: These gains will be maintained or further improve at the three month follow-up -post
test.

Research Sub-Questions
1. What are the perceptions of individuals who participated in the HIV/HCV
prevention intervention, Taking it to Treatment Court, in regards to:

7

a. the extent to which the intervention did or did not empower them to
engage in HIV/HCV risk reduction behaviors?
b. aspects of the HIV/HCV intervention that were influential at encouraging
them to engage in risk reduction behaviors?
2.

How closely does self-reported drug use correlate with urinalysis and arrest
records.

Delimitations
The delimitations of the study were as follows:
1. The study was delimited to persons enrolled in the Yellowstone County
Family Drug Treatment Court in Billings, Montana from August 2009 to April
2010.
2. Data were collected using a written questionnaire, focus groups, and court
provided urinalysis data and arrest records.
3. Data collected with the written questionnaire and focus groups were restricted
to participants’ self report.
4. The subjects for this study were voluntary participants who self selected
themselves.
5. The data collected was delimited to the Taking it to Treatment Court
curriculum which is a small program within the larger court system.
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Limitations
The limitations for this study were as follows:
1. Information gathered in this study from the written questionnaire was limited
to the voluntary action of the participants completing the questionnaire.
2. Information gathered in this study from focus groups was limited to
participants being able to attend the meetings and openly share their personal
information.
3. All of the information collected from the written questionnaire and focus
groups all based on self-reporting which can produce socially desirable
answers that are not honest or accurate.
4. The study was limited by the small population of participants in the
intervention.

Definitions of Terms
Child Abuse and Neglect: Any recent act or failure to act on the part of a parent or
caretaker which results in death, serious physical or emotional harm, sexual abuse
or exploitation, or an act or failure to act which presents an imminent risk of
serious harm (US: DHHS, 2009).
HCV: Hepatitis C, viral hepatitis contracted only through transmission of infected blood
and can lead to cirrhosis of the liver and/or liver cancer (CDC: Hepatitis C,
2008).
HIV: Human Immunodeficiency Virus, the virus that causes AIDS (CDC, 2006).
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Incidence: A measure of the frequency of occurrence of a disease or health problem in a
population based on the number of new cases over a given period of time (Green
and Krueter, 2005).
IDU: Injection drug use
Prevalence: A measure of the extent of a disease or health problem in a population based
on the number of cases (old and new) existing in the population at a given time
(Green and Krueter, 2005).
Recidivism: habitual relapse into crime and drug use (Huddleston, Marlowe, &
Casebolt, 2008).
Risk Reduction Behaviors: behaviors that lead to abstinence from drug use and
practicing safer sex (Semaan, Des Jarlais, & Malow, 2006)
Safe sex: the use of condoms while engaging in sexual behavior to reduce the risk of
sexually transmitted infections and HIV (CDC, 2010)
Seroconversion: The presence of HIV or HCV antibodies in previously seronegative
individuals, or becoming positive for HIV or HCV (Fuller, Ompad, Galea, Wu,
Koblin, & Vlahov, 2004).
TITTC: Taking it to Treatment Court
YCFDTC: Yellowstone County Family Drug Treatment Court
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CHAPTER II
Review of Literature

Traditionally there have been three options for the treatment of substance abuse:
incarceration, abstinence based programs, and harm reduction (WHO, 2006).
Incarceration involves punishing and removing illicit drug users from society using the
criminal justice system (Cusick, 2005). Abstinence based programs involve treating drug
use as a disease or illness through long-term hospitalization, methadone maintenance
programs, outpatient, and self help groups (WHO, 2006). Harm reduction interventions
suggest stopping the use of illicit drugs should not always be the top priority, but rather
attention should be focused on introducing harm reduction techniques to minimize the
risks associated with the injection of illicit drugs, like HIV or HCV contraction (Cusick,
2005). A fourth treatment option emerged in 1989 called drug court. Drug court is a
collaborative treatment option with participation from social services, counselors, judges,
and the judicial system (Huddleston, Marlowe, & Casebolt, 2008). Drug court seeks to
reduce the reliance on incarceration of non-violent drug abusers and fully rehabilitate the
individual by treating the addiction through abstinence based program options
(Huddleston et al., 2008).
This chapter is an overview of the current literature on drug courts as a treatment
option for drug users, the intervention strategies available for reducing HIV and HCV
incidence among drug users, and the intervention Taking it to Treatment Court that will
be evaluated in this study. The chapter is divided into six sections: 1) Drug Courts, 2)
Yellowstone County Family Drug Treatment Court, 3) Description of the intervention,
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4)HIV: injection drug use and prevention strategies, 5) HCV: injection drug use and
prevention strategies, and 6) Theory of Planned Behavior.

Drug Courts
The first drug court began operation in 1989 in Dade County, Florida as a response to
jails that were overcrowded with individuals on non-violent drug charges (Huddleston,
Freeman-Wilson, & Boone, 2004). The drug court model was the first attempt to
rehabilitate non-violent drug offenders utilizing the criminal justice system, social
services, counseling, and life skills training. The purpose of drug courts is to reduce
recidivism and substance abuse rates among nonviolent substance abusing offenders and
“increase the offenders likelihood of successful habilitation through early, continuous,
and intense judicially supervised treatment, mandatory periodic drug testing, community
supervision and use of appropriate sanctions and other habilitation services” (Huddleston
et al., 2004).
The Arrestee Drug Abuse Monitoring study (2000) found between one-fourth and
one-half of all adult males arrested, and one-half of all females arrested were at risk for
drug dependence. The National Survey on Drug Use and Health estimated there were
19.9 million illicit drug users aged 12 and older (DPHHS, 2008). The widespread
adoption of the drug court model is an attempt to reduce drug use rates in the United
States, and is gaining international popularity as well. As of December 31, 2007 there
were 2,147 drug courts operating in the United States, and this number has grown every
year since 1989 (Huddleston, Marlowe, Casebolt, 2008). Much public and private
funding has come forth to support drug courts over the years as well. The US General
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Accounting Office estimated in 1997 that from 1989 to 1997, over $80 million in federal
funding went to planning, implementing, improving, and evaluating drug courts across
the United States (Wilson, Mitchell, & Mackenzie, 2006).
The time a person spends in drug courts varies, but is generally one year to
eighteen months. Individuals have regularly scheduled hearings with a judge to discuss
their progress in the program. They also have scheduled urinalysis testing to monitor for
drug use (Huddleston et al., 2008). Drug court is a system of rewards and sanctions.
Rewards range from verbal praise to dropping the criminal charges upon successful
completion of drug court. Sanctions can range from verbal reprimands to incarceration.
Drug courts will also assist individuals with finding jobs or a home, reuniting families,
and improving social and life skills (Huddleston et al, 2008).
Family treatment drug courts (FTDC) operate on the same premise as adult drug
court: to reduce recidivism of drug abusers (Worcel, Furrer, Green, Burrus, & Finigan,
2008). The differences come from who is targeted and the ultimate goal. Clients served
in FTDCs are parents with substance abuse problems who are charged with child neglect
or abuse. The goal is to treat the parents’ addictions and provide a safe permanent home
for the child/ren, whether through reunification with the parent(s) or adoption. The
ultimate goal for parents in FTDC is not only avoiding jail time and dropped felony
charges, but reunification with their children and permanent custody (Worcel et al.,
2008). While reunification is preferred, it is not always in the best interest of the
child/ren.
As of December 31, 2007 there were 301 operating FTDC in the United States
(Huddleston et al., 2008). The first FTDC began operation in Reno, Nevada in 1995
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(Roche, 2008). These courts seek to break the cycle of addiction that has been correlated
with children of addicted parents. Children of addicted parents have a two to nine
percent increased risk for developing substance abuse problems later in life (Kumpfer and
Johnson, 2007). It is estimated that 25% of children, or 19 million, in the United States
under the age of 17 have a parent who is an alcoholic, and 12.7% of children, or 9.2
million, have parents with a chemical dependency (Kumpfer and Johnson, 2007). Having
a parent who uses alcohol or drugs increases the likelihood for the child to use later in
life. Families that drink alcohol raise youth that drink alcohol 82% of the time, compared
to families that abstain from alcohol use who raise children that abstained 72% of the
time (Kandel et al., cited in Johnson and Leff, 1999). A national survey conducted by the
National Center on Child Abuse and Neglect (2003), found that children of substance
abusing parents are three times more likely to be abused and four times more likely to be
neglected than children of parents who do not abuse alcohol and/or other drugs
(Gaudiosi, 2003).
Like drug court, family treatment drug courts require frequent court hearings
(often weekly), intensive judicial monitoring, provisions of substance abuse treatment,
drug screening, and rewards and sanctions based on progress through the court system
(Huddleston et al., 2008). One major difference between the court models are the
populations served; adult drug courts are predominantly male clients, while FTDC are
approximately 85% female (Worcel et al., 2007). Another difference is the goal of the
clients being served, as mentioned earlier. Drug court participants final outcome is
avoiding jail or prison time and having felony drug charges dropped. Family drug court
clients’ final outcome is reunification with their children, and hopefully full permanent
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custody (Huddleston et al., 2008). Parents in FTDC often times have many issues outside
of addiction that need addressing before reunification can occur. Parents must find
employment, housing, and demonstrate new parental skills before a child will be
returned. Successful treatment of the addicted parent has been positively correlated to the
likelihood of reunification with children (Worcel et al., 2008).
Research on whether FTDC is effective is limited. However, preliminary studies
are finding promising results. One retrospective study compared participants of a FTDC
to clients served through a more traditional child welfare system (Green, Furrer, Worcel,
Burrus, & Finigan, 2007). The results found parents were more likely to enter treatment,
and entered treatment more quickly, stayed in treatment longer, and were more likely to
complete treatment if they were enrolled in FTDC than the child welfare system. The
parents in FTDC were also reunified with their children more often than parents in the
child welfare program (Green et al., 2007). In a prospective follow up study, Worcel et
al., (2008) also found that women who entered FTDC were more likely to enter
treatment, entered treatment faster, stayed in treatment twice as long, and were twice as
likely to complete treatment as the comparison group. The comparison group was
comprised of women who had qualified for FTDC, but were unable to participate.
Participants of FTDC were also twice as likely to be reunified with their children as the
comparison group (Worcel et al., 2008). While preliminary data is showing positive
results for FTDC, more information in needed on why reunification is more prevalent for
the drug court model. Studies would benefit from an examination of the various
components of FTDC to determine which aspects reduce recidivism and increase the
likelihood of parent/child reunification.
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Yellowstone County Family Drug Treatment Court
Yellowstone County Family Drug Treatment Court began operating in June 2001 to serve
parents with substance abuse problems involved in the Child Welfare System in
Yellowstone County, Montana (For a complete list of participant criteria see Appendix
C) (Roche, 2008). Yellowstone County is located in south central Montana with an
estimated population of 139,936 (US Census Bureau, 2007). The mission of YCFDTC is
to reduce the rate of substance use among parents in the Yellowstone County who are
involved with the Child Welfare System, reunify parents with their children (when
appropriate), and to reduce the frequency of future drug offenses, criminal offenses, and
child maltreatment reports for YCFDTC participants (Roche 2008).
The goals of YCFDTC are to:
1. Increase the court’s influence over child abuse and neglect cases;
2. Promote children’s safety by reducing substance abuse and subsequent child
abuse and neglect among participants;
3. Establish permanency for children in the Child Welfare System, reunifying
children with parents whenever possible;
4. Address the family’s social and economic needs by identifying the needs and
strengths of the family that will aid them in leading a law abiding and substance
free life;
5. Strengthen the capacity of families to promote structure, guidance, and nurturance
for their children;
6. Increase participants overall physical and mental health status; and
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7. Develop and evaluate an operational model for family drug courts to be replicated
in other jurisdictions (Roche 2008).
To date YCFTDC has served 97 adults and 167 children. The minimum number of
months an individual must remain in the YCFDTC is twelve, but on average participants
take sixteen months to graduate (Roche, 2008). As of November 11, 2008, 31 of the 97
participants had graduated from YCFDTC, 26 participants were terminated after being in
YCFDTC for more than 60 days, 15 individuals were terminated within the first 60 days
of YCFDTC, one individual had their case transferred to Tribal Jurisdiction, 20 clients
are still active in the YCFDTC, four opted to return to the regular drug treatment after 60
days, and four opted for regular drug treatment within the first 60 days of YCFDTC
(Roche, 2008). The total number of participants is less than 97 because three of the
participants graduated twice from YCFDTC and one of the individuals terminated after
60 days was the same individual whose case was transferred to Tribal Jurisdiction
(Roche, 2008). Graduation is marked by reunification of the client with their child/ren
(Roche, 2008).
In comparison to traditional drug treatment programs, the YCFDTC has been
found to have a higher success rate of parent/child reunification. In Roche’s (2008)
evaluation of the YCFDTC, a comparison study was mentioned which examined
reunification rates between YCFDTC and a control population of parents with child
neglect and/or abuse charges related to substance abuse. Results found that permanency
of children was established in 74.5% of YCFDTC participants compared to 64% in the
control group. Forty nine percent of parental rights were terminated in the control group,
compared to 3.7% in the YCFTDC group. Finally, no parental rights were relinquished
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in the control group compared to 27.9% relinquished in the YCFTDC group (Roche,
2008). Further studies comparing YCFDTC to other similar treatment models could
reinforce the findings from this study to build a stronger case for YCFDTC and other
FTDC.

Description of the Intervention
Taking it to Treatment Court is a pilot intervention currently implemented as one of the
many aspects of the Yellowstone County Family Drug Treatment Court (YCFDTC) in
Billings, MT. It is a six hour group level intervention with a follow-up component
consisting of phone calls. The primary purpose of the intervention is to educate,
motivate, and support the practice of HIV and HCV risk reduction behaviors among
participants in YCFDTC.
Taking it to Treatment Court is based on Fishbein’s Theory of Planned Behavior
(TPB). This behavior change model distinguishes between attitudes toward a behavior
and attitudes towards the outcomes or goals of a behavior. This model demonstrates that
behavior can better be predicted based on the attitude toward the behavior, than the
attitude toward the outcome (Montano, Kasprzyk, & Taplin, 1997). For example, a
person’s attitude toward safer sex and abstinence from drug use is a better predictor of
those behaviors than a person’s attitude towards the risk of contracting HIV or HCV
from not practicing safer sex or abstaining from drugs.
Furthermore, Fishbein asserts the best way to predict a person’s behavior is by
ascertaining that person’s behavioral intention (Montano, et al, 1997). According to this
model, there are three direct determinants of behavioral intention:
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Attitude toward Performing the Behavior: attitude is determined by the individual’s
beliefs about the outcome of the behavior and by how much the individual values that
outcome.



Subjective Norm: subjective norm is determined by whether or not important or
significant people approve or disapprove of the behavior, weighted by the
individual’s motivation to comply with those significant people.



Perceived Behavioral Control: behavioral control is determined by the presence of
facilitators and barriers to behavioral performance, weighted by the perceived power
of each factor to facilitate or inhibit the behavior.
Each of the three determinants of behavioral intention is addressed by the

intervention TITTC. The following is a description of intervention components designed
to influence the model’s three main constructs.
Elements that Influence Attitudes:


Provide information about HIV/HCV transmission.



Increase perceptions of risk related to HIV/HCV in Montana.



Address negative attitudes regarding condom use and abstinence from drugs.



Facilitate the development of personal goals related to HIV/HCV prevention.



Discuss the relationship between personal goals and behaviors related to those
goals.

Elements that Influence the Participants Subjective Norm:


Increase awareness of social norms related to safer sex and drug use.



Provide support and a safe environment for discussion of social norms related to
safer sex and drug use.
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Provide positive role models whose lives demonstrate the successful attainment of
the desired behaviors.

Elements that Influence Perceived Behavioral Control :


Develop risk reduction goals and steps for achieving those goals.



Practice decision-making or problem-solving skills related to barriers to
practicing safer sex and/or abstaining from drug abuse.



Identify and develop methods for managing triggers for engaging in risky sex
behaviors and/or drug use.

Taking it to Treatment Court also incorporates some of the qualities of effective HIV
prevention interventions identified by Lyles et al. (2007) in a meta-analysis of 100
behavioral interventions. The qualities of effective interventions identified were:


The intervention is structured based on behavioral theory.



The intervention is facilitated by an individual that is indigenous to the target
population.



The intervention includes technical, personal and interpersonal skill-building
components.



The intervention utilizes a variety of delivery methods:


discussion,



demonstration,



lecture/instruction, and



role play.
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HIV and Injection Drug Use
The human immunodeficiency virus (HIV) is the virus that causes acquired
immunodeficiency syndrome (AIDS) (CDC, 2006). HIV lives within the infected
individual’s immune system by hosting in the white blood cells, or CD4+ lymphocytes.
HIV weakens the individual’s immune system over time leaving them more susceptible
to other illnesses and infections (NIDA, 2008). Contact with HIV infected blood or other
bodily fluid can transmit the virus. Practicing unsafe sex, vaginally or anally, and
injection drug use are the two highest risk factors for exposure to HIV (CDC: Basic
Statistics, 2008). The use of non-injection drugs and alcohol can impair judgment and
result in risky sexual behavior, such as not wearing a condom, increasing the possibility
of exposure to HIV as well. Although IDU is not the most common route of exposure for
HIV, IDU continues to expose and infect individuals with the virus indicating more
prevention and awareness efforts are needed (CDC: Basic Statistics, 2008).
The first case of HIV among persons who use injection drugs was in New York in
1981. The discovery of HIV among persons who use injection drugs did not gain much
national attention immediately, as it was considered to be a geographically isolated
incidence of HIV with low prevalence through 1984; only 1,353 cases of HIV were
reported up to this point (Des Jarlais, Friedman, & Ward, 1993). More sophisticated tests
for the presence of HIV/AIDS antibodies were developed and people were getting testing
around the world. Results from individuals’ tests revealed HIV was no longer a small
New York issue (Des Jarlais et al., 1993). HIV test results showed half the persons who
used injection drugs in New York and northern New Jersey’s were infected with HIV,
30% of Amsterdam’s IDU population were infected, and 50% of Edinburgh and parts of
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Italy’s IDU population were infected as well (Des Jarlais, et al., 1993). HIV was also
being transmitted to non-injecting sex partners and perinatally from infected mothers.
During the 1980s IDU was considered the most common route of exposure to HIV/AIDS
(Des Jarlais et al., 1993).
There are approximately 1.1 million people living with HIV in the United States. In
2006 there were 56,300 new cases of HIV diagnosed (CDC: Basic Statistics, 2008).
Compared with the rest of the United States, Montana has a low incidence of HIV, 21.1
cases per 100,000 and 1.7 cases per 100,000, respectively (MT-DPHHS, 2009). As of
February 17, 2010, there were 955 reported cases of HIV in Montana since 1985; of those
reported cases, 445 are living cases. During 2000 to 2008 there was anywhere from 16 to
27 new cases of HIV reported in Montana each year (MT-DPHHS, 2009). In 2008, 22
cases of HIV were reported and five of those cases were related to injection drug use. In
total, 13% of the reported cases in Montana are related to injection drug use (MTDPHHS, 2009). In February 2009 there were 122 known living cases of HIV related to
injection drug use in Montana, with 33 percent, or 40 of those cases in Yellowstone
County (MT-DPHHS, 2009).
Many factors contribute to the rapid spread of HIV among IDUs. The factors go
beyond the sharing of injection equipment. Des Jarlais and Semaan (2008) explain these
factors as:
1. Lack of information about HIV/AIDS in the local IDU population.
2. Restricted access to sterile needles and syringes for drug users. The restrictions
may be related to laws, such as requiring prescriptions for the sale of syringes and
drug paraphernalia, or from law enforcement practices, such as stationing police
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near syringe exchange programs or arresting drug users for drug residue in a used
syringe.
3. Situations that create rapid risk-partner change where IDUs may share needles
and syringes with many IDUs in a short time period. Examples include “shooting
galleries” in which a single needle and syringe are rented out to multiple users;
“dealer’s works,” where a drug dealer may lend the same needle and syringe to
many sequential customers; and “hit doctors,” who may use the same needle and
syringe to inject many clients who may have trouble injecting themselves.
4. People recently infected with HIV tend to be very infectious.
Another common practice among persons who use injection drugs is to pool
resources to purchase drugs. Pooling resources to obtain drugs increases the likelihood of
sharing injecting equipment and backloading. Backloading is the process of dividing
drugs using one syringe to fill the drug solution into the backs of other syringes. If the
parent syringe is not sterilized before distribution and contaminated with HIV, the
opportunity for HIV infection increases (Hahn, Page-Shafer, Lum, Bourgois, Stein,
Evans, Busch, Tobler, Phelps, & Moss 2002).

Prevention Strategies
The human immunodeficiency virus has no cure. There are several treatment options
available to slow down the progression of the disease which involves taking antiretroviral
drugs (CDC, 2009). The use of antiretroviral drugs reduces the plasma viral load in the
bloodstream to undetectable levels making an individual less infectious (CDC, 2009).
While antiretroviral therapy is not a cure, there have been advancements in these over the
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years. Since the introduction of combination antiretroviral therapy in 1996, the life
expectancy for person’s living with HIV have improved (Schackman, Gebok, Walensky,
Losina, Muccio, Sax, Weinstein, Seage, Moore, & Freedberg, 2006). With proper use of
combination antiretroviral drugs, life expectancy from the time of diagnosis is 24.5 years.
It was estimated in 2006 the lifetime cost to treat HIV for that amount of time was
$618,900 (Schackman et al., 2006).
As funding continually goes to finding a cure and vaccination for HIV, prevention
strategies remain crucial in slowing the spread of this disease (NIDA, 2008).
Intervention strategies to reduce the incidence of HIV among persons who use injection
drugs have evolved over time. Some intervention strategies include community outreach,
methadone treatment, needle exchange, and in-patient or out-patient abstinence programs
(Coyle, Needle, & Normand, 1998).
One of the earliest primary prevention strategies was community outreach, relying
on peers and indigenous members of the IDU community to educate out-of-treatment
persons who use injection drugs on the dangers of unsafe drug and sex practices using
culturally appropriate language and information. Outreach has been identified as one of
the top three prevention strategies for reducing incidence of HIV among IDUs (Coyle et
al., 1998). Strategies for community outreach are based on harm reduction principles like
face to face communication; HIV awareness, prevention, and available services; condom
distribution; bleach kit distribution for cleaning injection equipment; information on
available drug treatment options within the community; and HIV testing and confidential
risk assessments. Coyle et al.’s (1998) meta-analysis on the effectiveness of community
based HIV interventions for persons who use injection drugs found that between 24% and
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31% of outreach participants reported stopping injecting in the past 30 days. Participants
that did not stop injecting reported using less in the past 30 days, from 73 injections per
month to 45 injections per month (Coyle et al., 1998).
One study assessed the risk of sexual transmissions for HIV amongst persons who
use injection drugs compared to persons who use non-injection drugs (Booth,
Kwiatkowski, & Chitwood, 2000). Current drug users, defined as using in the past 30
days, and were out-of-treatment injectors and crack cocaine smokers, were recruited from
22 cities (n=26,982). The cities were part of a National Institute on Drug Abuse
Cooperative Agreement which was evaluating the effectiveness of community based
intervention strategies to reduce risk behaviors for HIV among persons who use injection
drugs (Booth et al., 2000). Participants were interviewed and asked questions about their
sexual risk behaviors in the 30 days prior. Results indicated 28 percent reported having
sex with two or more individuals, 23 percent had a partner who used injection drugs, 24
percent exchanged sex for drugs or money, and 80 percent reported not using a condom
during sex (Booth et al., 2000). Booth et al. (2000) conclude that addressing condom use
in prevention strategies for persons who use drugs remains crucial, as sexual transmission
remains a primary route of HIV exposure.

HCV and Injection Drug Use
Hepatitis C (HCV) is a viral infection of the liver transmitted through contaminated blood
and can lead to cirrhosis and liver cancer in chronic cases (CDC: Hepatitis, 2008). Prior
to its causative agents discovery in 1989, it was called parenterally transmitted non A and
non B hepatitis (WHO, 2000). It is considered the leading cause of chronic liver disease
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and liver transplants in the world. Approximately 80% of all HCV cases become chronic,
with 10-20% resulting in cirrhosis and 1-5% resulting in liver cancer (WHO, 2000).
HCV is also the most common chronic blood borne infection in the United States (CDC:
Hepatitis, 2008). HCV can be transmitted through blood transfusions from unscreened
donors, injection drug use, unsafe therapeutic injections and health care related
procedures (Shepard, Finelli, & Alter, 2005). It is estimated globally that 170 million
people are infected with HCV, or 3% of the total global population, with 3 to 4 million
new cases each year (WHO, 2000). The incubation period for HCV can be anywhere
from 15 to 150 days, with mild to no symptoms for years. The most common symptoms
include jaundice and fatigue (CDC: MTDPHHS, 2008).
Prior to 1990, blood transfusions were the most common route of exposure to
HCV in the United States (CDC: Hepatitis, 2008). Upon HCV’s discovery, blood was
screened more thoroughly, and the current risk for HCV from blood transfusions in the
United States is marginal. Injection drug use is now the most common route of exposure
to HCV in the United States and other developed nations (Edlin 2002; CDC: Hepatitis,
2008; WHO, 2000; Shepard et al., 2005). The United States is estimated to have 3.2
million people chronically infected with HCV, with an estimated 30,000 new cases each
year (CDC: Hepatitis, 2008). Of those new cases, approximately 68% are attributable to
IDU (Shepard et al., 2005). Studies funded by the National Institute on Drug Abuse
(2008) have found that within three years of injection drug use, most IDUs will contract
HCV, and 90% of HIV infected IDUs may also be infected with HCV.
As of December 31, 2008 there were 9,593 known cases of HCV in Montana
(Baus; CDC, 2009). Approximately 20-40 percent of those cases are related to injection
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drug use, or 1,919-3,837 cases respectively (Baus; CDC, 2009). In 2008 there were 943
cases of HCV, chronic and acute, reported in Montana and 218 of those cases were in
Yellowstone County. The overall rate for HCV in Montana is 97 cases/100,000
population (Baus; CDC, 2009). The number of individuals diagnosed with HCV under
the age of 25 was relatively high in Montana, 65 cases per 100,000, most likely indicating
injection drug use (MTDPHHS, 2009) and a need for earlier prevention efforts.
HCV prevalence in persons who use injection drugs range from 80-90%, and
estimates for the number of people who inject drugs is one to 1.5 million (Edlin, Kresina,
Raymond, Carden, Gourevitch, Rich, Cheever, & Cargill 2005). Intervention programs
targeted at reducing needle sharing for HIV prevention over the past 15 years were
effective, and now fewer IDUs share syringes. However, sharing injection equipment
remains a common practice and the reduction in needle sharing has not reduced the
incidence of HCV as effectively as HIV. Hahn et al. (2002) recruited persons who use
injection drugs and tested for HCV seroprevalence. The persons who use injection drugs
that tested negative for HCV were asked to return for a second screening to monitor for
seroconversion. Forty-eight participants seroconverted to HCV for a seroconversion rate
of 25.1/100 person years. Sixty-seven percent of the participants self-reported borrowing
a needle or syringe and 85% had ever shared drug preparation equipment (Hahn et al.,
2002).
The transmission of HCV is estimated to be 10 times more efficient than HIV,
and is generally a result of not only sharing syringes, but also sharing injection
equipment, like cookers (bottle caps, spoons, or any other container to dissolve drugs),
and cottons, i.e. filters to remove particulate matter while drawing up the drug solution
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into the syringe (Edlin et al, 2005). Backloading, like HIV, is another transmission route
for HCV (Hahn et al., 2002). Some other risk factors include pooling money together to
buy drugs, exchanging drugs for sex, and spending time in jail (Hahn et al., 2002).

Prevention Strategies
There is no vaccination or established cure for HCV, so prevention methods are crucial in
reducing HCV incidence (WHO, 2000; Edlin, 2005). Two antiviral drugs are prescribed
for HCV, interferon and ribavirin. Costs for these drugs remain high and the
effectiveness is low for chronic HCV seroprevalence. Interferon prescribed alone is
effective in 10-20% of patients. Ribavirin is ineffective on its own, but in combination
with interferon they are effective in 30-50% of patients (WHO, 2000). Approximately
20% of new HCV cases reverse on their own without any treatment, but it is unknown
why this occurs (Edlin, 2002). If detected early, HCV treatments can reverse diagnosis if
the virus is still in acute stages (Edlin et al. 2005). Given the minimal success of antiviral
drugs in chronic cases, primary and secondary prevention strategies remain critical in
preventing the spread of HCV. Most new infections in the US are amongst persons who
use injection drugs, and so “developing, testing, and implementing effective prevention
and treatment strategies for persons who inject drugs” is the primary way to control HCV
(Edlin, 2002, p. s210).
Prevention efforts to slow the spread of HCV amongst persons who use injection
drugs have coincided with HIV prevention efforts (Wright and Thompkins, 2006). Like
HIV, education is needed to inform persons who inject drugs of the dangers of sharing
needles and other injection equipment in regards to HCV exposure (Edlin, 2002).
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Providing sterile injection equipment and providing education on safer injection practices
remains the primary methods to reduce HCV incidence (Edlin, 2002). Edlin (2002)
suggests community based HCV prevention programs are needed as a means to provide
outreach, counseling and testing, education on safer injection practices, and link
individuals who are positive for HCV to medical care.
The same prevention efforts used to prevent the spread of HIV have not been as
effective at reducing the spread of HCV. A meta-analysis (Wright and Tompkins, 2006)
on the effectiveness of primary prevention interventions for HCV amongst persons who
use injection drugs found that needle exchange programs reduce the incidence of HCV,
though prevalence remains high, methadone maintenance programs marginally affected
the HCV infection rate, and limited evidence supports the efficacy of behavioral
interventions, bleach disinfectants, or drug consumption rooms. Given HCV
transmission is approximately ten times more efficient than HIV (Edlin et al, 2005);
efforts need to be directed at more than just using sterile syringes. Wright and Tompkins
(2006) cited a study conducted in the US which found some evidence that sharing
“cookers”, or spoons and/or metal containers to prepare and heat the drugs, presents a
greater risk for spreading HCV than sharing cotton filters or water.

Theory of Planned Behavior
The Theory of Planned Behavior (TPB) was developed by Ajzen as an extension of the
Theory of Reasoned Action (TRA). The TRA was developed by Fishbein and introduced
in 1967 (Montano, Kasprzyk, & Taplin, 1997). Measures of attitude and social
normative perceptions are determined to predict behavioral intention which in turn
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predicts behavior according to the TRA. An individual’s behavioral intentions are based
on:


attitudes toward performing the behavior and



subjective norm associated with the behavior (Montano et al., 1997).

Attitudes toward the behavior are based on:


behavioral beliefs toward the action and



an evaluation of the behavioral outcomes associated with action (Montano et al.,
1997).

Subjective norm is based on normative beliefs:


and whether or not significant others approve of the behavior, and



the motivation to comply with significant others beliefs on performing or
abstaining from the behavior (Montano et al., 1997).

The TPB added a construct examining how perceived control influences behavioral
intention as well. The perceived control is based on control beliefs concerned with:


resource availability for and obstacles to performing the behavior, weighted by



the perceived power of the resources and obstacles to facilitate or inhibit the
behavior (Montano et al., 1997). See Figure 1.
By influencing the predictor variables - attitude toward a behavior, subjective

norm, and perceived behavioral control - the likelihood of an individual adopting or
abstaining from a particular behavior increases. The more favorable the attitude and
subjective norm, and the greater the perceived control, the stronger a person’s intention to
perform a behavior becomes (Montano et al., 1997).
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All interventions based on the TPB should define their target behavior in terms of
its Target, Action, Context, and Time (TACT) (Francis, Eccles, Johnston, Walker,
Grimshaw, Foy, Kaner, Smith, & Bonetti, 2004; Ajzen, 2002). For example, consider the
behavior of abstaining from drug use. The target is current persons who use drugs, the
action is abstaining from drugs, the context is drug use or addiction, and the time is
during and post intervention. For safer sex practices, the target is people who do not
engage in safer sex practices, the action is condom use, the context is risky sexual
behaviors, and the time is during and post intervention.

Figure 1. Theory of Planned Behavior
Behavioral
Beliefs
Evaluations of
Behavioral
Outcomes

Attitude Toward
Behavior

Normative
Beliefs
Subjective Norm

Behavioral
Intention

Behavior

Motivation to
Comply

Control Beliefs
Perceived
Behavioral
Control
Perceived Power

Source: Ajzen and Fishbein, 1980; cited in Montano et al., 1997, p. 87.
To utilize the TPB, a questionnaire must be developed to assess the attitudes
toward a behavior, the subjective norm, and the perceived control (Ajzen, 2002). The
first step constructing a TPB questionnaire is to conduct elicitation interviews (Ajzen,
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2002). Elicitation interviews are semi-structured, open-ended interviews given to
individuals of the target population; for this study, current and past drug users with
children were interviewed by the Taking it to Treatment Court outreach workers
(Appendix A). The elicitation interviewer asks questions pertaining to positive and
negative outcomes or attributes associated with the desired behavior, individuals the
subject values and listens to on issues concerning the behavior in question, factors that
facilitate or obstruct the practice of the desired behavior, and feelings toward performing
the behavior (Montano et al, 1997). The information gathered from the elicitation
interviews is then analyzed for content on behavioral outcomes, normative referents, and
perceived control factors. The identified factors are used to develop TPB measures on
behavior, subjective norm and perceived control to be used on the final TPB
questionnaire (Montano et al., 1997).
The TPB questionnaires are given to members of the chosen target population and
scored. Each item that assesses the individuals attitudes towards a behavior, subjective
norm, or perceived control on the TPB questionnaire are determined by a seven-point
Likert-like Scale (Montano, et al, 1997). For example, an individual will mark where
their attitude toward a behaviors lies on a scale from strongly agree to strongly disagree.
Based on the individuals’ responses a score is calculated for each measure. The score is
used to predict whether or not the individual will engage or avoid the target behavior
(Ajzen, 2002). The results of the individuals’ responses are also useful to help
researchers identify factors that should be targeted for intervention efforts. The
intervention efforts should target all constructs of the TPB model in order to maximize
effectiveness. For example, “attempting to modify control beliefs concerning factors
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that facilitate carrying out one’s intention will not be effective if a person is not
motivated to perform the behavior in the first place. Conversely, changing attitude and
intention may not result in behavioral change if the person holds strong control beliefs
about conditions that constrain the behavior” (Montano et al. 1997, p. 109). Finally, it is
important to administer the TPB questionnaire before and after an intervention to
evaluate the impact the intervention has on individuals’ attitudes toward behavior,
subjective norm, and perceived control. If changes are not found, adjustment can be
made based on TPB measures (Montano et al., 1997).

33

CHAPTER III
Methods

Hepatitis C and HIV infection are serious threats to persons who use injection drugs
everywhere. Although HIV incidence rates are dropping among this population, HCV
infection remains high. More prevention efforts and educational programs are needed to
increase person’s who use injection drugs awareness of the behaviors that increase their
probability of contracting HIV and HCV. It is also important for persons who use
injection drugs to know their disease status so they can begin medical treatments if
necessary and learn how to prevent the spread of HIV and/or HCV. The intervention
examined in this study, Taking it to Treatment Court, aims to educate persons recovering
from drug use on harm reduction methods to decrease the spread of HIV and HCV. The
following sections examine the methods used to evaluate TITTC.

Research Design
This study utilized a mixed methods approach to program evaluation. Researchers
gathered information from participants enrolled in Taking it to Treatment Court in
Yellowstone County using both quantitative and qualitative data collection and analysis
methods. Two methods were used to collect quantitative data; 1) a pretest/posttest nonexperimental design and (2) collection of urinalysis and arrest report data from YCFDTC.
The survey consisted of four sections and was developed based on the Theory of Planned
behavior. Demographic data and information about the individual’s attitudes, beliefs,
subjective norms, and control factors related to safer sex practices and abstinence from
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drug use were collected. The survey also measured knowledge about HIV and HCV.
The survey was administered immediately before the intervention, two weeks post
intervention and at a three month follow-up. Researchers looked for changes over time
related to the TITTC intervention.
Urinalysis (UA) testing and arrest report data were collected from the YCFDTC.
Participants of the YCFDTC are remanded to frequent urinalysis testing. These data
were used as a comparison to the self reported data recorded for drug use on the survey.
The qualitative component of the study utilized focus group interviews.
Participants were asked to recall their experiences of participation in TITTC, what they
liked and did not like about the intervention, and the impact, if any, the intervention had
on their lives. Researchers looked for major themes regarding participants’ perceptions
of the effects of the intervention on their HIV/HCV risk behaviors.

Description of the Target Population
The target population for the Taking it to Treatment Court Evaluation Survey, Urinalysis
and Arrest Report Data consisted of the individuals enrolled in Yellowstone Family Drug
Treatment Court between August 2009 and April 2010. Individuals involved in the focus
groups were clients enrolled in the YCFDTC from December 2008 to December 2009.
The YCFDTC serves substance abusing parents with child abuse and/or neglect charges
related to drug use in Yellowstone County, Montana.

The families are involved with the

Montana Department of Health and Human Services-Child and Family Services Division
(Roche, 2008). Participants of YCFDTC must be at least 18 years old.
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Protection of Human Subjects
All research materials were approved by the Institutional Review Board (IRB) at the
University of Montana to ensure protection of human rights. Information was collected
on a voluntary basis and responses were anonymous (See Appendix F).

Sample Selection

Evaluation Survey, Urinalysis and Arrest Reports
The sample for the quantitative portion of the study consisted of all individuals enrolled
in Taking it to Treatment Court from August 2009 to April 2010. Clients of YCFDTC
during this time were given a research packet along with a $10 cash incentive at the start
of TITTC requesting their participation in the study. Willing participants were asked to
read and sign the consent form, complete the survey, and place the completed survey in a
sealed envelope that was collected by the intervention outreach worker. Given the low
number of clients enrolled in YCFDTC each year and the ethical issues associated with
withholding information, finding a control group was determined unfeasible.

Focus Group
The sample for the qualitative portion of the study consisted of clients enrolled in TITTC
from December 2008 to December 2009. Clients were approached by the outreach
workers to participate in a focus group. A written invitation was distributed to past
clients. The invitation contained a brief explanation of the focus group procedures and
asked the client to check a box indicating that they were “willing” or “not willing” to
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participate. Individuals who agreed to participate were asked to provide e-mail or phone
contact information and return the invitation to the outreach workers.

Data Collection
Data were collected using three different methods: a four part survey, focus group
interviews, and urinalysis (UA) and arrest reports. Survey and focus group data were
collected from intervention participants who volunteered for this study. Urinalysis and
arrest report records on the target population was acquired through the Drug Court
Coordinator of the YCFDTC.

Evaluation Survey Data
All clients participating in Taking it to Treatment Court were given a packet of
information before the intervention began. The packet included a cover letter, an
informed consent, and a $10.00 cash incentive to complete the survey. The packets were
handed out to participants by the outreach workers who conduct TITTC. Participants
were asked to place a unique identifier at the top of the survey for the purpose of
matching pre, post and three month follow-up surveys. When finished, the completed
surveys were placed in a manila envelope by the participants. The envelope was then
mailed to the researchers by the outreach worker.
The post test surveys were mailed to the study participants by the outreach
workers who routinely ask program participants’ to provide them with names and
addresses for the purpose of offering future social support and information as needed.
Follow-up surveys were mailed to participants two weeks post intervention and again at
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three months post intervention. Each follow-up packet contained a brief explanation of
the study, a survey, a $10.00 cash incentive, and a stamped, self-addressed envelope
addressed to the researchers at the University of Montana.

Focus Group Data
The outreach worker contacted former TITTC participants and invited them to participate
in a focus group. The outreach workers gave the names of willing participants to the
YCFDTC Coordinator who scheduled the time and place for the focus groups to occur.
Each focus group was held in a private conference room in the evening and lasted
approximately one hour. At the beginning of each session the researchers gave an
overview of the study and handed out consent forms. Prior to starting the group, study
volunteers were reminded the focus groups would be voice recorded, and no identifying
information would be linked to the information collected. A $30.00 cash incentive, pizza
and beverages were offered to the participants. Additionally, participants were reminded
they were free to discontinue their participation at any time and keep the incentive
money. During the focus groups one researcher asked the group questions while the
second researcher recorded responses on paper.

Urinalysis and Arrest Report Data
Participants who completed the survey filled out a separate form with their name, contact
information, and unique identifier. The unique identifier is the same identifier listed on
the participants’ surveys. The form was kept with the outreach workers who conducted
TITTC. When the UA and arrest report data were needed the outreach worker supplied
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the unique identifier to the YCFDTC Coordinator who matched the names of the clients
to the identifier. The researchers then contacted the YCFDTC Coordinator who supplied
the data via e-mail. Only the YCFDTC Coordinator and outreach worker had access to
the information connecting the clients’ name to the identifier. The data collected were
matched to the respective participant survey with the unique identifier. This allowed the
researchers to compare the UA and arrest report data with the self report survey data
without compromising the identity of the YCFDTC client.

Instruments

Taking it to Treatment Court: Evaluation Survey
Participants were given a survey pre and post intervention and again at a three month
follow-up. The survey was 14 pages and consisted of four sections: 1) Demographics, 2)
Theory of Planned Behavior Questionnaire, 3) HIV Knowledge Questionnaire, and 4)
HCV Knowledge Questionnaire. The survey responses were made anonymous to protect
the identities of clients served by YCFDTC (Appendix B). Informed consent forms and
completed surveys were collected separately to maintain anonymity of participants. The
following sections provide an in-depth examination of each part of the survey.

Section 1: Demographics
Participants were asked for basic demographic data such as age, sex, number of children,
race, education level, employment status, and marital status. A unique identifier question
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was also included at the top of the survey for the purpose of matching pre and post-test
surveys and UA and arrest report data.

Section 2: Theory of Planned Behavior
A questionnaire was constructed to measure the variables in the Theory of Planned
Behavior (TPB) related to intention to change behavior. Variables measured include
attitudes, beliefs, subjective norm, and control factors associated with safer sex practices
and abstinence from drug use (Appendix B).

Elicitation Interviews
A critical step in the application of the TPB involves conducting open-ended elicitation
interviews to identify the relevant behavioral outcomes, and referents for each particular
behavior and population under investigation (Glanz, Rimer and Lewis, 2002). Montano
et al (1997) recommends conducting elicitation interviews with individuals who are
currently engaging in the desired behavior and with individuals who are no longer
engaging in the desired behavior. Participants for the elicitation interviews were recruited
by the intervention outreach workers. The open-ended interview questions were sent via
mail on February 10, 2009 to sixteen individuals. Participants were asked their current
drug use status. The results were as follows:


eight individuals were recovering drug users,



two individuals were current users with intentions to stop using, and



six individuals were current drug users with no intention to stop using.
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The elicitation interview consisted of nine questions on drug use and nine
questions on safer sex practices (Appendix A). The responses to these questions were
used to develop the TPB questionnaire. Once it was constructed, a review of the TPB
questionnaire was undertaken by experts on HIV and HCV at the Montana Department of
Public Health and Human Services, researchers at the University of Montana, and the
intervention outreach workers. Upon completion of this review, the questionnaire was
pilot tested by former and current individuals who use drugs and have children, including
former participants of TITTC.

Pilot Test
The Theory of Planned Behavior Survey was pilot tested in July of 2009. The purpose of
the pilot test was to determine internal consistency and reliability. Fifty five pilot test
surveys were distributed by the TITTC outreach workers to current and past drug users.
Of these, fifty were returned for a response rate of 92.7 percent. Data were entered into
SPSS and Excel.
Internal consistency was calculated on the overall scores for the TPB Drug Use
and Safer Sex Questionnaire using Cronbach’s Alpha. Generally a reliability of 0.70 is a
sufficient score for a survey instrument; however, it is more desirable for each subscale to
fall in the range of 0.80 or higher, and the entire questionnaire to have a reliability of 0.90
or higher (Garson, 2009; uSPEQ, 2008; Gliem and Gliem, 2003). For the entire
questionnaire, including the Drug and Safer Sex Sections, Cronbach’s Alpha was (.916),
indicating high internal consistency. When ran individually, the Drug Use Section and
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the Safer Sex Section of the TPB Survey both had high internal consistency
independently, with α = 0.899 and α = 0.897, respectively.
The Drug Use and Safer Sex Questionnaires are divided into three sub sections
which correlate to the concepts of the TPB; attitude beliefs, subjective norm, and control
beliefs. The reliability co-efficient for each sub section of the Drug Use and Safer Sex
Questionnaires were calculated using Spearman-Brown split half reliability co-efficient.
The results were:


Drug Use: Attitude = .615; Subjective Norm = .53; Behavioral Control =
.737, and



Safer Sex: Attitude = .801; Subjective Norm = .667; Behavioral Control =
.854.

Generally, a co-efficient of 0.80 or higher is considered adequate reliability (Garson,
2009). A co-efficient of 0.80 or higher was found for the Safer Sex attitude and
behavioral control sections of the questionnaire. A common cutoff for reliability is a coefficient of 0.60 (Garson, 2009). The only section of the questionnaire that fell below
this mark was Drug Use: Subjective Norm. The Drug Use subjective norm may have
yielded a low co-efficient because this section consisted of only eight questions.
Increasing the number of questions on a survey can drive the alpha score up to an
adequate level (Garson, 2009).
The final TPB portion of the survey had 87 items, with 50 questions related to
drug use, 30 questions related to safer sex practices, and seven self report items regarding
drug use, safer sex practices and HIV/HCV health status. The TPB survey assessed three
areas: 1) attitudes and beliefs toward drug use and safer sex behaviors; 2) subjective norm
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based on factors that reinforce or dissuade drug use and safer sex behaviors; and 3)
feelings of control over the behaviors related to drug use and safer sex.
The TPB portion of the survey was scored based on recommendations by Francis
et al. (2004). Based on these recommendations, a total score for the three constructs attitudes towards a behavior, subjective norm and behavioral control - were obtained for
each participant. Each construct had an indirect measure. To calculate the score of an
indirect measure for any of the three constructs the belief score related to that construct
was multiplied by the corresponding motivation to comply score (Francis et al., 2004).
The resulting products for each section were summed to create an overall score for
attitude, subjective norm, and control belief. The higher an individual’s scores were, the
more likely they are to perform the behavior in question. There are three direct measures
questions on the survey that utilize the five point Likert-like scale as well. Each direct
measure question has a four part answer. To calculate the score of a direct measure
question the point values corresponding to the answers supplied are averaged giving a
value between one and five. The higher the score the more likely a participants is to
perform the behavior in question (Francis et al, 2004).

Section 3: HIV Knowledge
The HIV knowledge questionnaire used in this study was developed by Carey, MorrisionBeedy, and Johnson (1997) (Appendix B). This questionnaire has 45 true/false questions
related to the transmission, prevention, and consequences of HIV infection. The HIV
Knowledge Questionnaire (HIV-K-Q) was extensively tested by the authors. Carey et
al.’s (1997) study included a scale construction and formative evaluation, item and factor
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analysis, generalization of the factor solution, reliability, validity, reading level, and
completion time required. Measures found the HIV-K-Q was internally consistent and
stable over three month intervals. Validity analysis also found the HIV-K-Q to not be
associated with other constructs like social desirability, negative or positive mood, selfesteem, depression, dyadic adjustment, sexual satisfaction, or attitudes towards condoms
(Carey et al., 1997). The HIV-K-Q is written at a sixth grade level and takes
approximately seven minutes to complete (Carey et al., 1997).
Two additional items were included in the HIV-K-Q regarding anti-retroviral drugs.
Given the HIV-K-Q is an older instrument it did not have items addressing persons who
are positive for HIV and take anti-retroviral drugs. The following true/false/don’t know
questions were added:
1. A person cannot get HIV by having sex with a person who is HIV+ but is taking
anti-retroviral drugs, and
2. A person cannot get HIV from a person who is HIV+ and has a zero viral load.
The questionnaire was scored by summing the total number of correct answers.
The purpose of the HIV-K-Q was to determine if there were gains in HIV knowledge
among the participants in Taking it to Treatment Court over time.

Section 4: HCV Knowledge
The Hepatitis C Knowledge Questionnaire (HCV-K-Q) was developed by the researchers
(Appendix B). This 22 item questionnaire was developed based on HCV knowledge
gained by the researchers through a systematic review of literature about transmission,
prevention, and consequences of HCV infection. Content and face validity were
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established through a review of the HCV-K-Q by a national HCV expert, HIV/STD
prevention staff at MT DPHHS, university professors, and the Taking it to Treatment
Court outreach workers.

Pilot Test
Once the survey was reviewed by experts it was pilot tested by 51 YCFDTC participants
enrolled or previously enrolled in Taking it to Treatment Court in July of 2009. A total
of fifty five surveys were mailed out, for a return rate of 92.7 percent. The results of the
pilot test were not included as part of the final study, but were used to improve the
content and face validity of the survey. Data were entered into SPSS and Excel.
Spearman Brown split half reliability coefficient was calculated and the instrument was
found to have adequate reliability (0.793) (Garson, 2009).
The questionnaire was scored by summing the total number of correct answers.
The purpose of the HCV-K-Q was to determine if there were gains in HCV knowledge
among the participants in TITTC over time.

Taking it to Treatment Court: Focus Groups
Questions for the focus groups were developed by the researchers to obtain an
understanding of the participants’ perceptions of Taking it to Treatment Court and the
outreach workers who conduct the intervention. The Theory of Planned Behavior served
as the foundation for the development of the focus group interview guide. Questions
asked pertained to the effects the intervention may or may not have had on their attitudes,
sense of support, and confidence to abstain from drugs and practice safer sex. When
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necessary, more specific questions were asked regarding how the intervention influenced
knowledge about prevention, transmission, and consequences of HIV and HCV infection
and if the knowledge gained increased the likelihood to engage in preventative behaviors
(See Appendix D).

Taking it to Treatment Court: Urinalysis and Arrest Reports
Urinalysis and arrest report data were collected for the purpose of comparing
participants’ self-reported behavior on the TITTC evaluation survey with more objective
information. Yellowstone County Family Drug Treatment Court requires all participants
to be drug and alcohol tested on a weekly basis by urinalysis (UA). Drug testing is
randomized among clients, so individuals are unaware of when or how many times a
month they will be called for screening (Roche, 2008). Results of all UAs are given to
the YCFDTC Coordinator daily and included in the participant’s Client Status Report that
is used during clients’ treatment meeting and hearings (Roche, 2008). YCFDTC
maintains participant’s arrest reports while in treatment as well. These records were
compared to the TPB intentions to abstain from drug use scores to look for a correlation
between intentions to abstain from drugs and actually abstaining.

Data Analysis

Taking it to Treatment Court: Evaluation Survey
Data from the questionnaires were entered into the SPSS statistical package and
descriptive statistics were calculated. The degree to which intentions to change risk
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behaviors were affected by the intervention was examined and described for each of the
three constructs of the behavior change model. HIV and HCV knowledge scores were
calculated as well. Mean scores, ranges, and standard deviations for pre, post and three
month follow-up survey results were presented in charts. Repeated measures ANOVA
was used to determine statistically significant differences in TPB construct scores and
HIV and HCV knowledge scores over time. Due to the small n in the study combined
with the low return rate on the three month follow-up survey, the researchers also ran ttests on the pretest and two week posttest data to determine if there were any short term
statistically significant gains.
In addition, the relationship between the intent to perform behaviors (the predictor
variable reported on the post-test survey) and the actual behaviors (the criterion variable
representing mandatory drug tests) was examined. Bivariate correlation statistics was
used to calculate an r² value. Researchers’ predict a positive relationship exists between
intent to perform a behavior and actually performing the behavior once participants
complete TITTC.

Taking it to Treatment Court: Focus Group
Analysis of the focus group data was based on qualitative research techniques (Creswell,
1998). The focus groups were taped and notes were taken. Immediately following the
focus group, the researchers’ recorded on a contact summary sheet general impressions of
the interview process including length of interview, location, a general physical
description of the interviewees, and any notable or unusual circumstances. The tapes
were transcribed completely and compared to the notes to check for accuracy. The first
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part of the analysis involved reading the transcriptions through numerous times and
taking notes in the margins. The emergent themes and concepts were organized into
separate categories. Lastly, the emergent themes were compared and condensed into
overall themes and sub-themes.

Taking it to Treatment Court: Urinalysis and Arrest Reports
Urinalysis (UA) and arrest report data were obtained from the YCFDTC Coordinator
three months post intervention. Data were collected from three months pre intervention
to three months post intervention, corresponding to the self report questions on drug use
and arrest history from the evaluation survey. Results of the UA were recorded on a
dichotomous scale as passing the drug screen, indicating no presence of drugs, or failing,
indicating drug use. These results were compared to the self-reported drug use behavior.
Arrest report data was examined in terms of recidivism. The use of UA and arrest report
data ultimately contributed to the validation of responses from the evaluation survey and
determined if a correlation existed between intention to abstain from drugs and actual
behavior.
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CHAPTER IV
Results

The purpose of this study was to evaluate Taking it to Treatment Court, an HIV and HCV
prevention intervention for clients of the Yellowstone County Family Drug Treatment
Court. This study examined the effects of the intervention on participants’ knowledge of
HIV and HCV and on their behavioral intentions to practice safer sex and abstain from
drugs. The following section reports the findings of this study.

Taking it to Treatment Court: Evaluation Survey

Section 1: Demographics
Eleven participants entered the study; however one dropped out of the YCFDTC system
during the evaluation period of this study and did not complete the post test evaluations.
Data from this participant was excluded in this analysis. Of the ten participants in the
study there were:


8 females and



2 males.

The average age of participants was 28.2, with a range from 20 to 37 years old. Race was
indicated as follows:


6 white (non-hispanic),



2 American Indian/Alaskan Native,



1 Hispanic/Latino/Chicano, and
49



1 not indicated.

Nine participants were heterosexual and one was bi-sexual. Seven participants indicated
they were single parents, one was separated, and one lived with a partner. The total
number of children participants reported was as follows:


1 child (n=3),



2 children (n=3),



3 children (n=1), and



4 children (n=3).

Four participants did not have a high school diploma, four received a high school
diploma or GED, and two indicated they had attended some college. Six participants
indicated they were employed; however none had an income level over $10,000 per year.
The majority (n=7) had income levels below $6,000 and two ranged from $6,000 to
$10,000. One participant did not indicate an income level.

Section 2: Theory of Planned Behavior
All ten participants completed the Taking it to Treatment Court pre-evaluation survey and
two weeks post intervention evaluation survey for a 100% return rate. The three month
follow-up survey was completed by five participants. The remaining five participants
were sent the three month follow-up survey, but failed to return it for a response rate of
50%. The low return rate of the three month follow up survey resulted in the researchers
calculating a paired sample t test with the pretest and two week posttest survey. A
repeated measures ANOVA was run on the five participants with all three data points. A
p value of .05 was set to determine significance.
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Score ranges on the Theory of Planned Behavior survey are based on a five point
Likert-like scale and total number of questions. The lower the score the lower an
individual’s intention is to perform a behavior, the higher the score the higher an
individual’s intention is to perform a behavior. For each section of the TPB survey
scores were calculated to determine the possible range of total scores. The ranges are
listed in the tables below.

Drug Use Survey
The TPB Drug Use Survey was designed to measure participants’ intentions to abstain
from drug use. Mean scores, ranges, and standard deviations for the drug use section of
the questionnaire were calculated. Pre, post and three month follow-up scores for the
total questionnaire and three subscales of the TPB are illustrated in tables’ one through
six below. Results of the paired samples t test and repeated measures ANOVA follow the
respective table.

Table 1. TPB Drug Use Survey – Total Scores

TPB INTENTION TO ABSTAIN FROM DRUGS
Mean Score

Range

353.0 (n=10)

267-433

Standard
Deviation
51.8

401.5 (n=10)

281-508

68.2

387.8 (n=5)

286-435

58.4

(24-600 possible)

Pre Test
Post Test
3 Month
Follow Up

The TPB Drug Use Survey was designed to measure participants’ overall
intentions to abstain from drug use, including attitudinal, normative and control beliefs.
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A paired samples t test was calculated for the TPB Drug Use Survey total scores from
pretest to two week posttest. The t value = -2.313 and p= .046, which is significant at the
p=.05 level. A repeated measures ANOVA was run on the TPB Drug Use Total scores
for pre, post, and three month posttests for the five participants with complete data sets.
No significance was found (p=.433).
A score below 216 on this subscale indicates a weak intention to abstain from
drug use, while a score above 216 indicates a strong intention to abstain from drug use.
The three calculated means for this construct show that overall participants had strong
intentions to abstain from drug use. The range column shows that none of the individual
participants scored below a 216 on the pretest indicating each participant had a relatively
strong intention to abstain from drugs prior to engaging in TITTC. The intentions
towards abstaining from drugs scores fell during the three month follow-up but remained
higher than the baseline scores.

Table 2. TPB Drug Use Attitude Sub-Scale Scores

TPB DRUG USE ATTITUDE SCORES
Mean Score

Range

151.8 (n=10)

98-195

Standard
Deviation
32.3

184.3 (n=10)

129-234

33.2

162.8 (n=5)

94-196

40.7

(10-250 possible)

Pre Test
Post Test
3 Month
Follow Up

The TPB Drug Use Attitude sub-scale was designed to measure attitudinal beliefs
towards abstaining from drug use. Attitudes toward abstaining from drug use are based
on behavioral beliefs toward the action and an evaluation of the behavioral outcomes
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associated with action (Montano et al., 1997). A paired samples t test was calculated for
the TPB Drug Use Attitudes scores from pretest to two week posttest. The t value =
-2.43 and p= .038, which is significant at the p=.05 level. A repeated measures ANOVA
was run on the TPB Drug Use Attitudes scores for pre, post, and three month post tests
for the five participants with complete data sets. No significance was found (p=.379).
A score below 90 on this subscale indicates a negative attitude toward abstaining
from drug use, while a score above 90 indicates a positive attitude toward abstaining
from drug use. The three calculated means for this construct show overall participants
had positive attitudes towards abstaining from drug use. The range column shows that
none of the individual participants scored below a 90 on the pretest indicating each
participant had a relatively positive attitude toward abstaining from drug use prior to
engaging in TITTC. The positive attitudes were maintained through the three month
follow up.

Table 3. TPB Drug Use Subjective Norm Sub-Scale Scores

TPB DRUG USE SUBJECTIVE NORM SCORES
Mean Score

Range

77.7 (n=10)

40-95

Standard
Deviation
16.1

82.0 (n=10)

50-100

16.3

86 (n=5)

80-95

6.5

(4-100 possible)

Pre Test
Post Test
3 Month
Follow Up

The TPB Drug Use Subjective Norm sub-scale was designed to measure
normative beliefs towards abstaining from drug use. Normative beliefs are based on
whether or not significant others approve of the behavior, and the motivation to comply
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with significant others beliefs regarding performing or abstaining from the behavior
(Montano et al., 1997).
A paired samples t test was calculated for the TPB Drug Use Subjective Norm
scores from pretest to two week posttest. The t value = -.908 and p= .388, which is not
significant at the p=.05 level. A repeated measures ANOVA was run on the TPB Drug
Use Subjective Norm scores for pre, post, and three month post tests for the five
participants with complete data sets. No significance was found (p=.827).
A score below 36 on this subscale indicates a negative normative belief, while a
score above 36 indicates a positive normative belief. The three calculated means for this
construct show overall participants had positive normative beliefs towards abstaining
from drug use. The range column shows that none of the individual participants scored
below a 36 on the pretest indicating each participant had relatively positive normative
beliefs toward abstaining from drugs prior to engaging in TITTC. The positive normative
beliefs were maintained through the three month follow up.

Table 4. TPB Drug Use Control Sub-Scale Scores

TPB DRUG USE CONTROL SCORES
Mean Score

Range

123.5 (n=10)

89-149

Standard
Deviation
22.9

135.2 (n=10)

90-179

31.5

139 (n=5)

112-191

30.7

(10-250 possible)

Pre Test
Post Test
3 Month
Follow Up

The TPB Drug Use Control sub-scale was designed to measure participants’
perceived control beliefs towards abstaining from drug use. Perceived control beliefs are
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based on resource availability for and obstacles to performing the behavior, weighted by
the perceived power of the resources and obstacles to facilitate or inhibit the behavior
(Montano et al., 1997). A paired samples t test was calculated for the TPB Drug Use
Control scores from pretest to two week posttest. The t value = -1.376 and p= .202,
which is not significant at the p=.05 level. A repeated measures ANOVA was run on the
TPB Drug Use Control scores for pre, post, and three month follow up post tests for the
five participants with complete data sets. No significance was found (p=.458).
A score below 90 on this subscale indicates low perceived control beliefs towards
abstaining from drug use, while a score above 90 indicates high perceived control beliefs
towards abstaining from drug use. The three calculated means for this construct show
overall participants had positive perceived control beliefs towards abstaining from drug
use. The range column shows that a participant scored just below 90 on the pretest,
however overall participants had relatively high perceived control beliefs prior to
engaging in TITTC. The positive control beliefs were maintained through the three
month follow up.
Two direct measures questions were asked related to drug use in the attitude and
control section. For a direct measure, the participant is given a statement followed by
four sub scales consisting of dichotomous terms ranked from 1 through 5 on a Likert-like
scale. For example, the phrase “Overall drug use is …” is followed by four pairs of terms
such as “enjoyable” and “not enjoyable”. The answers provided by participants are
averaged with one indicating negative attitudes or feelings of control towards the
behavior and five indicating positive attitudes or feelings of control towards the behavior.
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The following are tables with the means, ranges and standard deviations of these
constructs.

Table 5. TPB Direct Measure Drug Use Attitude Scores

TPB DIRECT DRUG USE ATTITUDE SCORES
Mean Score

Range

3.4 (n=10)

1.75-5

Standard
Deviation
1.2

3.5 (n=10)

2.5-5

0.72

3.86 (n=5)

3.3-4

.31

(1-5 possible)

Pre Test
Post Test
3 Month
Follow Up

A paired samples t test was calculated for the TPB Direct Drug Use Attitudes
scores from pretest to two week pos test. The t value = -.214 and p= .835, which is not
significant at the p=.05 level. A repeated measures ANOVA was run on the TPB Direct
Drug Use Attitudes scores for pre, post, and three month post tests for the five
participants with complete data sets. No significance was found (p=.569).
A score below three on this subscale indicates negative direct attitudinal beliefs,
while a score above three indicates positive direct attitudinal beliefs. The range column
shows some participants scored below and above a three on the pretest and two week
posttest, indicating direct attitudinal beliefs prior to engaging in TITTC were mixed. By
the three month follow up all participants (n=5) had scores over three.
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Table 6. Direct Measure Drug Use Control Scores

TPB DIRECT DRUG USE CONTROL SCORES
Mean Score

Range

3.9 (n=10)

1-5

Standard
Deviation
1.6

4.8 (n=10)

3.75-5

0.41

4.85 (n=5)

4.25-5

.34

(1-5 possible)

Pre Test
Post Test
3 Month
Follow Up

A paired samples t test was calculated for the TPB Direct Drug Use Control
scores from pretest to two week posttest. The t value = -1.75 and p= .114, which is not
significant at the p=.05 level. A repeated measures ANOVA was run on the TPB Direct
Drug Use Control scores for pre, post, and three month post tests for the five participants
with complete data sets. No significance was found (p=.738).
A score below three on this subscale indicates low direct control beliefs, while a
score above three indicates high direct control beliefs. The range column shows some
participants scored below and some scored above a three on the pretest, indicating direct
control beliefs prior to engaging in TITTC were mixed. By the two week posttest all
participants had scores over three which were maintained over time.

Safer Sex Survey
The TPB Safer Sex Survey was designed to measure participants’ intentions to practice
safer sex, as defined by using condoms. Mean scores, ranges, and standard deviations for
the safer sex section of the questionnaires were calculated. Pre, post and three month
follow-up scores for the total questionnaire and the three subscales of the TPB are
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illustrated in tables seven through eleven below. Results of the paired samples t test
follow the respective table.

Table 7. TPB Safer Sex Survey - Total Scores

TPB SAFER SEX TOTAL SCORES
Mean Score

Range

189.2 (n=10)

117-243

Standard
Deviation
47.8

198.2 (n=10)

99-317

71.5

212.2 (n=5)

125-276

63.1

(15-375 possible)

Pre Test
Post Test
3 Month
Follow Up

A paired samples t test was calculated for the TPB Safer Sex Total scores from
pretest to two week posttest. The t value = -.592 and p= .568, which is not significant at
the p=.05 level. A repeated measures ANOVA was run on the TPB Safer Sex Total
scores for pre, post, and three month post tests for the five participants with complete
data sets. No significance was found (p=.914).
A score below 135 on this construct indicates weak intentions to practice safer
sex, while a score above 135 indicates strong intentions to practice safer sex.

The range

column, shows that some individual participant’s intentions to practice safer sex were
weak prior to entering TITTC. The weak individual intentions towards practicing safer
sex were unchanged through the three month follow up. Findings also show some
individual’s intentions were strong from pretest and were maintained through the three
month follow up test.
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Table 8. TPB Safer Sex Attitude Sub-Scale Scores

TPB SAFER SEX ATTITUDE SCORES
Mean Score

Range

104.8 (n=10)

65-155

Standard
Deviation
23.6

97.5 (n=10)

58-157

32.1

109 (n=5)

68-137

32.0

(8-200 possible)

Pre Test
Post Test
3 Month
Follow Up

The TPB Safer Sex Attitude sub-scale was designed to measure attitudinal beliefs
towards practicing safer sex. A paired samples t test was calculated for the TPB Safer
Sex Attitude scores from pre test to two week post test. The t value = .816 and p= .435,
which is not significant at the p=.05 level. A repeated measures ANOVA was run on the
TPB Safer Sex Attitudes scores for pre, post, and three month post tests for the five
participants with complete data sets. No significance was found (p=.743).
A score below 72 on this subscale indicates a negative attitude toward practicing
safer sex, while a score above 72 indicates a positive attitude toward practicing safer sex.
The range column shows that some individual participant’s attitudes towards practicing
safer sex were negative prior to entering TITTC and stayed negative over time. Findings
also show some individual’s attitudes were positive from pretest and were maintained
through the three month follow up test.
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Table 9. Safer Sex Subjective Norm Sub-Scale Scores

TPB SAFER SEX SUBJECTIVE NORM SCORES
Mean Score

Range

33.9 (n=10)

3-65

Standard
Deviation
21.1

37.4 (n=10)

7-75

27.2

45.2 (n=5)

25-70

21.3

(3-75 possible)

Pre Test
Post Test
3 Month
Follow Up

The TPB Safer Sex Subjective Norm sub scale was designed to measure
participants’ normative beliefs towards practicing safer sex. A paired samples t test was
calculated for the TPB Safer Sex Subjective Norm scores from pretest to two week
posttest. The t value = -.655 and p= .529, which is not significant at the p=.05 level. A
repeated measures ANOVA was run on the TPB Safer Sex Subjective Norm scores for
pre, post, and three month post tests for the five participants with complete data sets. No
significance was found (p=.718).
A score below 27 on this subscale indicates negative normative beliefs towards
practicing safer sex, while a score above 27 indicates positive normative beliefs toward
practicing safer sex. The range column shows that individual participant’s normative
beliefs towards practicing safer sex range from very negative to very positive prior to
entering TITTC and remain this way over time.
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Table 10. TPB Safer Sex Control Sub-Scale Scores

TPB SAFER SEX CONTROL SCORES
Mean Score

Range

50.5 (n=10)

31-80

Standard
Deviation
17.9

63.3 (n=10)

30-95

24.2

58 (n=5)

32-74

17.4

(4-100 possible)

Pre Test
Post Test
3 Month
Follow Up

The TPB Safer Sex Control sub scale was designed to measure participant’s
perceived control over practicing safer sex. A paired samples t test was calculated for the
TPB Safer Sex Control scores from pre test to two week post test. The t value = -1.636
and p= .136, which is not significant at the p=.05 level. A repeated measures ANOVA
was run on the TPB Safer Sex Control scores for pre, post, and three month post tests for
the five participants with complete data sets. No significance was found (p=.325).
A score below 36 on this subscale indicates low perceived control beliefs towards
practicing safer sex, while a score above 36 indicates high perceived control beliefs
toward practicing safer sex. The range column shows that some individual participant’s
perceived control beliefs were slightly negative prior to entering TITTC and stayed
slightly negative over time. Findings also show some individual’s perceived control
beliefs were high from pretest and these beliefs were maintained through the three month
follow up test.
One direct measure question was asked related to safer sex attitudes. The
following is a table with the means, ranges and standard deviations of this construct.
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Table 11. TPB Direct Measure Safer Sex Attitude Scores

TPB DIRECT SAFER SEX ATTITUDE SCORES
Mean Score

Range

3.6 (n=10)

2.3-5

Standard
Deviation
.85

3.8 (n=10)

2.5-5

.82

4.3 (n=5)

3-5

.84

(1-5 possible)

Pre Test
Post Test
3 Month
Follow Up

A paired samples t test was calculated for the TPB Direct Safer Sex Attitude
scores from pre test to two week post test. The t value = -1.956 and p= .082, which is
approaching significance at the p=.05 level. A repeated measures ANOVA was run on
the TPB Direct Safer Sex Attitudes scores for pre, post, and three month post tests for the
five participants with complete data sets. No significance was found (p=.410).
A score below three on this subscale indicates negative direct attitudinal beliefs
towards practicing safer sex, while a score above three indicates high direct attitudinal
beliefs towards practicing safer sex. The range column shows some participants scored
below and above a three on the pretest and two week posttest, indicating direct attitudinal
beliefs prior to engaging in TITTC were mixed. By the three month follow up all
participants (n=5) had scores of three or above.

Self Reported Data
At the end of the TPB Survey, participants were asked 11 questions related to number of
times the participant has been in treatment or arrested; drug use history, including
frequency and drugs used; arrest charges; if the participant had been tested for HIV or
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HCV and the results; and risk factors for HIV and HCV (See Appendix B).

The results

of HIV and HCV testing and risk factors are reported below (See Table 12). Results of
the participants’ responses in regards to treatment, drug use history, and arrest report data
are examined further in the Urinalysis and Arrest Report Section.
The pretest TPB self reported data indicated that nine out of the ten participants
had been tested for HIV, and none of those individuals tested were positive. Half of the
participants (n=5) had been tested for HCV, and three had positive test results (See Table
12). Participants were asked to indicate any risk factors they had for HIV and HCV. The
results were as follows:


injection drug use (n=5),



having unprotected anal sex with men (n=3),



having unprotected heterosexual sex (n=6), and



not a member of a risk group (n=2).

The sum total of these results exceeds ten as participants were able to indicate more than
one risk factor.
The two week posttest TPB Self Reported data indicated again that nine out of the
ten participants had been tested for HIV, however only eight negative test result
responses were given. One participant’s test result datum was missing. At the two week
follow up, nine participants indicated they had been tested for HCV, and four had
positive test results (See Table 12). Participants were asked again to indicate any risk
factors they had for HIV and HCV. The only result that changed from pre to two week
post was the category Not a member of a risk group (n=4). The one participant who had
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not been tested for HIV was the same participant not tested for HCV. By the three month
follow up, this individual indicated she had still not been tested.

Table 12. HIV and HCV Testing and Test Results

HIV/HCV TESTING AND RESULTS

HIV Pre Test
HIV Post Test
HCV Pre Test
HCV Post Test

Participants Tested

Participants Tested
Positive

9 (n=10)

0

9 (n=10)

0

5 (n=10)

3

9 (n=10)

4

Section 3: HIV Knowledge Questionnaire
Ten participants completed the pre and posttest HIV Knowledge Questionnaire for a
return rate of 100 percent. Five participants completed the three month follow up HIV
KQ, for a return rate of 50 percent. Means, ranges and standard deviations for the pre,
post and follow-up scores are reported in table 13 below. The low return rate of the three
month follow up survey resulted in the researchers calculating a paired sample t test with
the pretest and two week posttest survey. A repeated measures ANOVA was run on the
five participants with all three data points. A p value of .05 was set to determine
significance. Results of the paired samples t test and repeated measures ANOVA follow
table 13.
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Table 13. HIV Knowledge Questionnaire Scores

HIV KQ DESCRIPTIVE STATISTICS
Mean Score

Range

37.1 (n=10)

15-43

Standard
Deviation
8.0

39.8 (n=10)

31-44

3.8

37 (n=5)

27-43

6.37

(47 Total Points)

Pre Test
Post Test
3 Month
Follow Up

A paired samples t test was calculated for the HIV KQ from pretest to two week
posttest. The t value= -.923 and p=.38, which is not significant at the p=.05 level. A
repeated measures ANOVA was calculated for the HIV KQ for pre, post, and three
month post tests for the five participants with complete data sets. No significance was
found (p=.427).

Section 4: HCV Knowledge Questionnaire
Ten participants completed the pre and posttest HCV Knowledge Questionnaire for a
return rate of 100 percent. Five participants completed the three month follow up HCV
KQ, for a return rate of 50 percent. Means, ranges and standard deviations for the pre,
post and follow-up scores are reported in table 14 below. The low return rate of the three
month follow up survey resulted in the researchers calculating a paired sample t test with
the pretest and two week posttest survey. A repeated measures ANOVA was run on the
five participants with all three data points. A p value of .05 was set to determine
significance. Results of the paired samples t test and repeated measures ANOVA follow
table 14.
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Table 14. HCV Knowledge Questionnaire Scores

HCV KQ DESCRIPTIVE STATISTICS
Mean Score

Range

10.6 (n=10)

5-17

Standard
Deviation
4.5

16.2 (n=10)

12-20

2.5

16 (n=5)

11-19

3.32

(22 Total Points)

Pre Test
Post Test
3 Month
Follow Up

A paired samples t test was calculated for the HCV KQ from pre test to two week
post test. The t value= -5.154 and p=.001, which is significant at the p=.05 level. A
repeated measures ANOVA was calculated for the HCV KQ for pre, post, and three
month post tests for the five participants with complete data sets. There was a significant
difference (p=.003). The significance was between the pre and three month follow up
survey (p=.028), and the pre and two week post survey was approaching significance
(p=.064). It is important to note the pre and posttest mean scores represent all ten
participants. The mean differences between pre, post and three month follow up tests are
different for the five participants with complete data sets.

Taking it to Treatment Court: Focus Groups

Description of Focus Groups
Two focus groups were held on Wednesday December 16, 2009 in Billings, Montana.
The meetings were held in a private conference room in the Family Child Services
Building each lasting approximately one hour. The YCFDTC Coordinator was present at
the start of both groups to introduce clients to the researchers. The groups were seated
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around a conference table, dress was casual, and the participants were all friendly and
familiar with one another.
The first focus group was held at 4:00 PM and had six participants; one male and
five females. No demographic information was collected from the group, however based
on the researcher’s observations the group consisted of three non-Hispanic whites and
three Native Americans aged 25 to 45. The second group immediately followed the first
group at 5:15 PM. The members of this group were four females, and based on
observation were three non-Hispanic whites and one Native American aged 21 to 45.
Participants were asked how long ago they completed Taking it to Treatment Court. One
participant had taken it as recent as three months prior, while the rest of the group had
completed the course nine months to one year ago.

Researcher‟s Impressions of Focus Group Process
The purpose of the focus groups was to obtain general impressions of TITTC from
former clients. On a whole the participants of these focus groups were compliant,
talkative, and friendly. All participants contributed to the discussion, although there
tended to be dominant voices in the dialogue. Each group had slightly different dynamics
that will be discussed further in the following paragraphs. In general, the participants
seemed unenthusiastic about participating in the focus group, but eager to assist the
outreach workers in bettering the program and obtaining funding. They appeared slightly
confused as to why researchers were asking questions about a program they took nearly a
year ago and eager to conclude the meeting. Receiving the incentive money and getting
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free food and beverage seemed to be the motivating factors to participate in the focus
group.

Focus Group #1
In the first group, a participant’s daughter was present. She was approximately 10 years
old, and during the focus group she sat and drew pictures. At one point in time she got
up and left the room and came back minutes later which was distracting. Often time’s
participants would make light of a discussion by using jokes. The male in the group was
used as a scapegoat for many participants to divert attention away from the questions
posed by the researchers. The male and one of the females in the group were in a
relationship which may have affected the way either of these individuals participated in
the discussion. One participant in this group was very quiet and only answered questions
when directly asked. A few times members of this group would ask if the meeting was
nearly over, which would make other members of the group anxious to leave.

Focus Group #2
The second group had three very talkative women and one relatively quiet woman. All
four women knew each other well and had a lot to say that did not pertain to the questions
asked. As in the first group, jokes were used frequently as a way to lighten the mood.
One of the participants was much younger than the rest and she was used as a scapegoat
to divert attention away from the questions posed. This same young woman would
provide elaborate stories that were not necessarily related to TITTC or the outreach
workers who conduct the intervention. Her stories were distracting for the rest of the

68

group and the researchers had to continually bring the conversation back to the
intervention.
Overall, the depth of information provided by these two groups was very minimal.
Neither group directly answered the questions related to the sense of support the
intervention gave them. The majority of answers pointed to the intervention being
primarily a source of information about HIV and HCV.

Emergent Themes
Data were analyzed for common themes, patterns, and constructs during the focus
groups. Themes that emerged during the focus groups overlapped between the two
groups since the same questions were posed. The following is a look at the major themes
discussed by the participants during the focus groups.

Taking it to Treatment Court was a Positive Experience
In general, the participants believed the intervention was a positive experience. Taking it
to Treatment Court was described as informative, positive, relaxed, comfortable,
thorough, personal, a chance to meet other YCFDTC participants, and delivered by
genuine, caring outreach workers with whom they could identify.
“I thought that it [Taking it to Treatment Court] was very positive, very um, it
taught you a lot. It taught me a lot about what I didn‟t know about the things that
were taught.”
“Um, when I was in the group that all of us were in…were in the Drug Court
Program, and so I got to know people that were in that [program] better than I
would have had that group not been in place.”
“Very relaxed and comfortable. It wasn‟t you know, awkward talking about that
stuff you know.”
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“They [outreach workers] kept it interesting, they didn‟t…They didn‟t make you
feel uncomfortable. You were welcome no matter what, they were funny, and they
also got the point across. [Be]cause I didn‟t know nothing about that stuff.”
“They [outreach workers] were really involved with it [Taking it to Treatment
Court] because he [an outreach worker] had it [HCV] and it, you know, that just
made it more, ah, more sincere and more honest from them really.”
“Yeah, it was realistic. It‟s not just something, it‟s not going to happen to me,
and here I mean, it [HCV] happened to him [outreach worker], and it could
easily happen to me. And it just made it more realistic.”
“Once you get through the program, you say, „Wow! That was good!‟”

Taking it to Treatment Court Encouraged Participants to Get Tested
There were many times throughout the focus groups that participants brought up the
importance of getting tested for HIV and HCV and how Taking it to Treatment Court
encouraged them to get tested. Participants also felt it would be a good idea to offer
onsite HIV and HCV testing as part of TITTC in the future.
“Yeah, for me it was like, once you learned the different ways that is it possible to
contract, like Hep C, like if you have it, using his razor blade, you know, to shave
my legs or something, or sharing tooth brushes, I mean you want to get tested.”
“I just got tested for all of that [HIV and HCV].”
“For Hep C, um, they gave me a couple of mail in test kits.”
“I think that if they have taken out the option to get tested there on the spot, if that
was taken from the class, I think it should be put back in.”
“Yeah, [be]cause a lot of times you think, um, well I never shot up or anything
like that, so…But then they‟re [the outreach workers] like [say]you know, even
using tooters can do it [lead to HIV/HCV infection]…”
“Oh yeah. Yeah, I mean, even though I wasn‟t an IV user, but you know, I had
unsafe protection sex before, and you know, she [the outreach worker] let me
know. Especially with someone you really know.”
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Outreach Workers Encourage Safer Sex
It was very clear during both focus groups that the outreach workers reinforced the
importance of practicing safer sex. Safer sex was defined during the focus groups as
using condoms. Participants’ mentioned several times that their level of support for
practicing safer sex was increased by the outreach workers. This was achieved by the
outreach worker’s dedication to distribute free condoms and lube to YCFDTC clients,
education about condom negotiation, and supplying knowledge about resources for
reproductive health issues.
“Oh yeah, she always has them [condoms], every day she shows up there is bags
of them.”
“I mean she offers them out, she does mention this is a great way to not pass this
[HIV] on…She [the outreach worker] does it, she gives them [condoms] to you,
and I don‟t know… The first time I came home I had like two drawers of them.
They are everywhere, so I mean what more of a sense of support for using
condoms can you have then everywhere you look there is one.”
“But also, you know, they you know, they tell you where you can get like free
testing and where you can go and get like free condoms, and you know birth
[control]…”
“They [the outreach workers] just reinforced it [safer sex] a lot.”
“I think I remember her [outreach worker] saying something about it
[monogamous relationships]. [Be]cause I was like, I remember saying something
about being married and she said that there is always a possibility [for
contracting a disease] that he goes out or you know something.”
“Yeah, I‟m not scared to tell a dude to put a condom on anymore.”
“Maybe more comfortable than you had ever thought of it [condoms] before. It
was kind of like a, oh my god I couldn‟t bring that [condoms] up. I‟d be so
embarrassed. But now, I mean, now you know how to bring that up. It‟s not
hard.”
“To be able to talk to a partner about it [using condoms] maybe.”
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“You know, and it‟s more likely for women to carry condoms in their purses now
than it is for a man to carry a condom around with him. Or when he knows he‟s
going to have you know, sex, he‟ll be prepared and have them in his car or
whatever, they just don‟t do it. So that‟s their excuse to not use them, well I don‟t
have it. And if you have them, there is no reason to not use it.”
“Yeah, they gave out free condoms and lube and it was awesome!”

Participants gained knowledge about HIV and HCV
Participants believed the most valuable aspect of the intervention was an increase in their
knowledge about HIV and HCV. Gains in knowledge about HIV and HCV were the
primary themes discussed during both focus groups. Participants felt the intervention did
a good job of presenting HIV and HCV information by clearing up questions or myths
pertaining to the viruses and did not leave them with any questions. Overall, participants
felt they learned more about HCV than HIV. The HIV knowledge was described as an
upgrade of knowledge, whereas the HCV knowledge was all fairly new material.
Participants mentioned specific knowledge gains in the following areas: statistics about
HIV and HCV prevalence; where and how to get tested; effects of HIV and HCV on body
organs; effects of injection drug use as well as non-injection drug use on the risk of
disease transmission; methods for protecting oneself from disease transmission; HIV and
HCV etiology and transmission; importance of bleaching drug injecting equipment;
negotiating condom use; resource availability for reproductive health; and effects of drug
use on important others.
“I liked how they showed you hands on what it did to your body, what it does to
your body, your liver, and just talk about the liver, it was nice to see the damage.”
“Just learning the statistics on HIV and Hep C in Montana and how long Hep C
is alive.”
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“I didn‟t know anything about Hep C until I took the class, so it was good
information for me.”
“For me it was like kind of a different scope because I have been recently
diagnosed with Hep C. I have had it for awhile and didn‟t know. So that class
really, it had a big impact because it taught me you know, what was really
involved, you know. Because I have a lot of misperceptions about how easily my
kids could get it, or you know. And it really put my mind at ease and educated me
on, on how to keep everybody safe and at the same time, you know, I was going
through the HCV treatments. They had a lot of information that really set my
mind at ease, so.”
“Yeah, just it was kind of like the, how long it [HCV] survives airborne, it‟s, I
didn‟t, I wouldn‟t imagine it being able to live that long.”
“I think mine was learning about the statistics back home in ____ County, you
know because I grew up on that reservation and I know all those people pretty
much, and to know that like so many of them you know, [have HIV and HCV], and
they don‟t even know it.”
“I felt, I felt pretty secure when I left it, you know. I had enough knowledge to
keep everybody I knew safe. I mean, I wasn‟t asking questions, I really felt like
they covered most of the area that I would have had any questions about.”
“[I learned] how to protect yourself and you know, be aware of what you can do
to yourself. And how easy it is to get, and it is a permanent thing.”
“I do think people mostly feel like, yeah, I kind of know how it [HIV] is passed,
and Hep C is really the one that we don‟t know.”

Taking it to Treatment Court Encouraged Abstaining from Drugs
Participants felt TITTC provided some motivation to engage in protective behaviors
related to abstaining from drugs. Participants mentioned TITTC was an incentive to
abstain and offered ways in which the knowledge from the intervention has impacted
their thinking. One participant mentioned a time when she relapsed and how she kept
reminding herself of the information she learned from the intervention.
“It was an incentive [to abstain].”
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“More reasons to think about not doing it [use drugs].”
“It may have, it have done it [made me feel more confident to abstain from drug
use] in the fast line of…of, actually catching the disease, that you can catch from
using drugs. Opposed to, oh well, I‟ll never catch this [HIV or HCV]. You know
what I mean? Kind of got the education on it, so you are more likely to think
about it, instead of just being like, oh, it‟s never been something I had to worry
about now, so let‟s not even think about it.”
“It is scary to just, to realize how many times I put myself in a situation where I
could have gotten it [HIV or HCV].”
“You thought twice before you stuck a needle in your arm that you thought was
dirty.”
“It was like, when I relapsed it was always in the back of my head about like
passing a loker [glass pipe used to smoke meth] around because the chapped lips.
It dehydrates you and that pipe, when you pass it around, you know, you can get it
that way because, it was always in the back of my head.”

Participants Respected and Trusted the Outreach Workers
Focus group participants thought very highly of the outreach workers who conduct
TITTC. They were described as being knowledgeable, sincere, honest, relatable,
personal, funny, supportive, passionate, compassionate, easy to understand, comforting
and helpful. Participants were willing to listen to the outreach workers because they were
indigenous to the population which allowed the outreach workers to build trust and
rapport. Participants of the focus group also talked about whether or not the intervention
would work if different outreach workers conducted TITTC. In general participants felt
any outreach worker would need to be similar in lifestyle, attitude, passion and
experience as the outreach workers who conduct this intervention. Participants
mentioned if the outreach workers were not indigenous to the population they would be
less respected, effective, or trusted.
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“I think their personalities bring a lot to it and makes you want to actually, to
listen and pay attention.”
“[T]hey make you laugh, and I mean they make you comfortable.”
“It might be the same if you had other people that were like, like them. You know,
had that like you know attitude.”
“People that have lived our life and know what that‟s like, it might have the same
effect.”
“[I] think that part of it for me was just that they really make you want to pay
attention [be]cause they are interesting and they relate, you know, you can relate
to them, and I don‟t know. You know, maybe if someone comes in with text book
knowledge of it, I would be bored to tears.”
“It would only be a good program on its own if there was two people involved
that had the history and the stories to back up the program. Because you have
two people that don‟t have anything to do with what you‟re teaching, nobody
wants to pay attention to those people because they don‟t, they don‟t have
firsthand experience…You want firsthand experience if you are being taught
something honest.”
“They are genuine, they‟re like us. It‟s not just like they are just doing it for the
paycheck…”
“[It] has to be someone who want to do that [teach an intervention]. I mean the
reason that it is so effective is because they [the outreach workers] are interested
in it.”
“I mean, I think the way they have it set up is great and I don‟t know how you
could improve upon that, and that‟s just kind of, I think that if you had two
different people in there and they did it the same way it might not work as well. I
think it‟s just that you got the two right people doing the right thing.”
“It makes me feel more secure [to know the outreach workers are available when
you need them]. I mean, you really could call them.”
“I thought it was very important [the outreach workers offered follow up
support]. Very important. And anytime that I have seen her [outreach worker],
like at Drug Court when she is there, or whatever, there is so much support from
them about anytime contact me, you know. Her little card that she hands out, you
know.”

75

Taking it to Treatment Court: Urinalysis and Arrest Reports
Participants were asked 11 self report questions at the end of the Theory of Planned
Behavior survey. The results of their answers to the drug use history and arrest report
questions are examined below. The responses given by the participant were compared to
actual Urinalysis (UA) and arrest report data supplied to the researchers by the YCFDTC
coordinator and compared to scores on the TPB survey. Researchers were looking for
correlations between intentions to abstain from drugs and actually abstaining. Each week
participants of YCFDTC are remanded to UA screening. The results of these tests are
placed in the client’s permanent file along with any records of recent arrests (Roche,
2008). Researchers obtained this information through the use of unique identifiers to
maintain anonymity of participants. The YCFDTC Coordinator matched the names of
the client to their unique identifier supplied on the study survey. Results were obtained
via email.
One of the self report questions asked participants to write in their primary drugs
of choice prior to entering YCFDTC. All ten participants responded. The results are
based off the pre test survey data and were as follows:


Alcohol (n=9)



Marijuana (n=7)



Methamphetamine (n=1)



Opiates (n=2)



Prescription drugs (n=3)

The total for drugs used exceeds ten as participants indicated more than one drug of
choice.
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Participants of this study were asked to recall how many times in the three months
prior to YCFDTC they used drugs and/or injection drugs and how many times they had
used drugs and/or injection drugs in the past three months prior to TITTC. Responses to
the drug use frequency questions were answered by checking one of four boxes: daily;
weekly (1-2 times/week); monthly (1-2 times/month); or never. The following tables
show the frequencies of answers given. The three month follow up posttest results
represent the five participants with complete data sets.

Table 15. Self Report Frequencies of Drug Use Pretest

Frequencies of Drug Use Prior to YCFDTC and Past 3
Prior to TITTC: Pretest
DU Prior
YCFDTC
Daily
Weekly
Monthly
Never

8
1
0
0

IDU Prior
YCFDTC

DU Past 3
Months

IDU Past 3
Months

1
1
2
6

1
1
1
7

0
0
0
10

Table 16. Self Report Frequencies of Drug Use Three Month Follow Up Posttest

Frequencies of Drug Use Prior to YCFDTC and Past 3
Months: Three Month Post Test
DU Prior
YCFDTC
Daily
Weekly
Monthly
Never

3
1
0
1

IDU Prior
YCFDTC

DU Past 3
Months

IDU Past 3
Months

1
0
1
3

0
0
0
5

0
0
0
5
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Participants were asked an open ended question in regards to arrest history. They
were to write in any charges they had incurred during the past three months. One
participant indicated he/she had been arrested for a felony drug charge, three driving
under the influences, one fleeing and eluding, and stealing a car. Another participant
indicated he/she had been arrested for possession of drug paraphernalia and an
outstanding warrant. All other participants indicated this question was not applicable or
they had no arrests.
Participants’ UA and arrest records were obtained from three months prior
TITTC, to three months post TITTC. The results of this data were compared to overall
intentions to abstain from drug use scores on the TPB survey. Researchers were looking
for correlations between intentions to abstain from drugs and actually abstaining based on
UA data. The following graphs plot the overall behavioral intention to abstain from
drugs score with the total number of positive UAs for each participant. A positive UA
indicates the presence of drugs in the urine. The two week posttest survey data was not
included in this analysis. The data only includes the five participants with complete data
sets, as these were the only participants that complete UA data was made available.
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Figure 2. Pretest Drug Use Survey Scores and positive UAs.

TPB Intention to Abstain from Drug Use
Pretest Scores compared to Positive UA's
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Of the five participants included in this data set above, the two participants that
self-reported no drug use in the past three months had positive UAs. The other three
participants that self-reported they used drugs in the past three months did not have
positive UA results. A correlation co-efficient was run using Microsoft Excel. There
was not a correlation between pretest drug use scores and positive UA results (r²=0.002).
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Figure 3. Three Month Follow up Drug Use Survey Scores and Positive
UAs.

TPB Intention to Abstain from Drug Use
3 Month Posttest Scores compared to
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Of the five participants included in this data set above, three participants selfreported they never used drugs in the past three months, which was confirmed by the UA
results. The other two participants self-reported they never used drugs in the past three
months, and both of these individuals had positive UA results. A correlation coefficient
was run using Microsoft Excel. There was not a correlation between three month posttest
drug use scores and positive UA results (r²=0.059).
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CHAPTER V
Discussion

The purpose of this study was to evaluate the HIV/HCV prevention intervention, Taking
it to Treatment Court. This evaluation examined whether the program (1) increased
participants’ knowledge about HIV/HCV risk reduction behaviors and (2) if their
intention to abstain from drug use and/or practice safer sex was affected. Analysis of
results from the TPB Questionnaire, the HIV and HCV Knowledge Questionnaire, and
focus group interviews are discussed below.

Intentions to Abstain from Drug Use
There was overall statistically significant short term gains in intention to abstain from
drug use based on the Theory of Planned Behavior Drug Use Survey between the pre and
two week posttests when examining total scores. Long term gains in intention to abstain
from drug use were not seen from the pre to three month follow up surveys when
examining the five participants with complete data sets.
In analyzing each subsection of the TPB Drug Use Survey the attitude subsection
was the only section found to have short term statistical significance. The significant
gains in attitudinal scores from pre to posttest may be a result of increased knowledge
about the dangers of HCV when using drugs. Attitudes toward a behavior are based on
behavioral beliefs toward the action (If I use drugs I am at high risk for HCV) and an
evaluation of the outcomes associated with the behavior (HCV can be a deadly disease)
(Montano et al., 1997). Focus group participants mentioned TITTC focused more on
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knowledge about HIV and HCV then on support to abstain from drugs, which may be
why statistically significant gains were not found for normative beliefs.
Statistically significant gains were not found in the Normative Belief, Control and
Direct Measures sub scales from pre to posttest. While the lack of statistical significant
may indicate that the intervention had little effect on normative beliefs and perceptions of
control, it is important to note that the lack of significance also may be related to the
small sample size or too few questions related to each subscale. Despite the lack of
statistical significance, means scores did increase from pre to posttest.
Whether or not TITTC improved normative and control beliefs directly cannot be
determined. Participants came into TITTC with high normative beliefs towards
abstaining from drugs which may be a result of a strong sense of support from the
YCFDTC and this support may have increased over time. Control beliefs were also high
at pretest and continued to increase over time. Control beliefs may have increased over
time as a result of abstaining from drugs for longer periods of time. Participants may be
gaining skills from other YCFDTC programs that allow them to feel more in control
towards abstaining from drugs.
The YCFDTC is designed to encourage participants to abstain from drugs through
the use rewards and sanctions, and ultimately reunification with their children (Roche,
2008). Overtime, it would be expected that participants’ intentions to abstain from drug
use would increase as the incentives become greater. It is hard to definitively conclude
that the intentions to abstain from drug use are a result of TITTC independently.
However, based on the pretest/posttest results it would appear that TITTC may have
contributed to YCFDTC participants’ gains in intentions to abstain from drug use.
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Intentions to Practice Safer Sex
Long and short term gains in intention to practice safer sex were not statistically
significant. This lack of statistical significant may indicate that the intervention had little
effect on intentions to change risky sexual behavior, or the lack of significance may be
related to the small sample size or to measurement error. Ambivalence about intentions
to practice safer sex, as indicated by the pretest scores, could have contributed to the lack
of statistically significant findings. It may also be that a six hour intervention was not
long enough to encourage long lasting behavioral change. Research indicates that
effective behavioral interventions usually last between 9 and 18 hours and involve more
than one meeting (Lyles et al., 2007). This supposition is supported by the fact that
changes in attitudes toward drug use, which were reinforced everyday as part of the
YCFDTC, were found to be statistically significant, while changes in attitudes toward
safer sex that were encouraged only during the six hour TITTC program were not.
It is important to note that although there was no statistically significance change
from pre to posttest, means scores did increase over time. This increase in scores from
pre to posttest is supported by comments from focus group participants who indicated
TITTC did a good job of offering free condoms and lube, encouraging safer sex practices,
and condom negotiation.

HIV Knowledge
The results of the paired samples t test showed the short term and long term gains in HIV
knowledge were not significant from pre to posttest. This lack of significance may be
due, in part, to the high pretest scores. The pretest scores indicated that participants had a
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good understanding of HIV prevention and transmission before participating in TITTC.
Since HIV has been the focus of prevention efforts for 17 years (Kops, 2010) high pretest
scores may be indicative of the effectiveness of these prevention efforts.
Despite the high scores on the HIV knowledge questionnaire, analysis of
individual questions reveals areas that would benefit from more emphasis. Many
participants incorrectly answered questions on the posttest and three month follow up
tests related to the types of body fluids that transmit the virus. Many also were unaware
of behaviors that put them at risk for HIV as well as being unaware of the effects of
antiretroviral drugs on transmission risk.
Results from the focus group interviews tended to reinforce the results from the
HIV knowledge questionnaire. Most participants indicated TITTC was a good refresher
of information on HIV and cleared up any myths they believed in regards to HIV
transmission and prevention. However, outside of the current epidemiologic information
presented, none of the focus group participants stated that the HIV knowledge provided
was new material. Overall, this may indicate that less time needs to be spent on general
information about HIV during interventions. Instead, intervention specialists may want
to focus on common myths or misunderstandings about HIV/AIDS transmission and
prevention.

HCV Knowledge
Participants in TITTC showed significant short term gains in HCV knowledge scores
from pre to two week post evaluations. Long term gains in HCV knowledge were upheld
from pretest to three month follow up when analyzing the five participants with complete
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data sets. Pretest scores on the HCV Knowledge Questionnaire were much lower on
average than pretest scores on the HIV Knowledge Questionnaire. This is not surprising
given that HIV has been the focus of prevention efforts for the past 17 years, while HCV
prevention has received minimal funding and little attention in the state of Montana
(Kops, 2010) or nationally (Edlin, 2002).
Results of the focus groups reinforced the findings from the HCV questionnaire.
The majority of participants indicated they had little to no prior knowledge about HCV
before TITTC. Most participants indicated the education about HCV in TITTC was
valuable and necessary. Despite the significant gains in knowledge from pre to posttest
on the HCV questionnaire, there were several questions many participants answered
incorrectly on both the pretest and the posttest. Questions most frequently missed were
those related to: the prevalence of HCV; knowledge about symptoms of acute and
chronic HCV; and modes of transmission. Emphasis on these topics may encourage
uninfected individuals to avoid behaviors that put them at risk for infection, as well as
encourage those infected with HCV to recognize symptoms, seek treatment, and avoid
further disease transmission.
The effects of the intervention on HCV knowledge and behavior are further
reinforced by the findings from the question regarding HCV testing. Prior to TITTC,
only five participants had been tested for HCV. Two weeks post intervention nine
participants had been tested. This may indicate that TITTC was an incentive for HCV
testing. Offering this service as part of TITTC may ensure all participants are tested in
the future.
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Perceptions of Taking it to Treatment Court
The general impressions based on the focus group data were Taking it to Treatment Court
offered more in the way of knowledge than encouraging abstinence from drug use or
practicing safer sex. Participants mentioned they felt encouraged by the outreach
workers to engage in these behaviors, but more emphasis was placed on the intervention
educating clients about the risks of HIV and HCV.
Many of the comments provided during the focus groups were validated by the
TITTC Evaluation Survey results. Participants mentioned the intervention taught them
more about HCV than HIV, and the survey data showed significant gains in HCV
knowledge, but not HIV knowledge. The gains in knowledge may be why a short term
change in attitudes toward drug use was found.
Studies have tried to capture what makes an HIV intervention effective. Lyles et al.
(2007), in a meta-analysis of 100 behavioral interventions, describes the qualities of an
effective HIV prevention intervention. The qualities of effective interventions identified
in the meta- analysis that TITTC meet are:


the intervention is based on behavioral theory,



the intervention encourages social or group support,



the intervention is facilitated by an individual that is indigenous to the target
population,



the intervention helps participants develop plans or set goals for risk reduction,



the intervention includes technical, personal and interpersonal skill-building
components, and



the intervention utilizes a variety of delivery methods:
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Discussion



Demonstration



Lecture/Instruction



Role play (Lyles et al., 2007).

While these qualities are satisfied by TITTC and were mentioned by participants of the
focus groups, some important qualities are missing. Important qualities missing from
TITTC include:


9-18 hours of intervention time over more than one session,



stress reduction and management skill building, and



identification and management of triggers for risky sexual behaviors.

The interventions examined by Lyles et al. (2007) which contained these components
saw significant gains in condoms use, reduced number of sexual partners, reduced
incidence of sexually transmitted infections, and reduced IDU or needle sharing at three
to twelve month follow ups. These behaviors would not only protect against HIV
transmission, but HCV transmission as well. By following more of these
recommendations from Lyles et al. (2007), TITTC may become a more effective
behavioral intervention to minimize risky sexual and drug use behaviors.

Urinalysis and Arrest Report Correlation
Data collected from the YCFDTC coordinator indicated that no participants were arrested
during the study time. Two participants indicated they had been arrested, however the
arrests specified may have occurred before the time of the study and so were not relevant.
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Urinalysis data showed positive UA results for three of the five participants with
complete data sets. The self-report and UA data did not match for any of the pretest
surveys; participants either checked they never used drugs and did, or checked they used
drugs but had negative test results. For the three month posttest data, three participants
self report answers matched the UA data and two participants indicated they never used
drugs but had positive test results. There was no correlation between any of this data.
The lack of correlation may be a result of small sample size, participants offering socially
desirable answers, or high behavioral intentions not resulting in direct behavioral change
immediately.

Limitations
Limitations exist within all study designs that may impact the results. There were many
limitations within this study that could have impacted the data collected. The following
is an examination of the limitations.
This study was limited to a small sample size. Eleven participants entered the
study, ten completed the two week follow up, and five completed the three month follow
up. The participant that dropped out of the study was terminated from the YCFDTC and
so was unable to complete the study. While the sample size was small, the ten
participants comprised the total population of clients in YCFDTC during the time of the
study. However, only five of the ten participants completed all three data points,
resulting in a less than desirable sample size and only half the total population.
Clients of YCFDTC are required to attend weekly hearings with the drug court
judge, counseling sessions, and other courses and groups throughout the 12 to 18 months
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they are enrolled in the program. Taking it to Treatment Court is only one six hour
intervention offered to these clients. It is however, the only intervention that provides
information on HIV and HCV prevention. While the gains in HCV knowledge may be
attributed to TITTC, it is difficult to discern if changes in intention to abstain from drugs
were the result of participation in TITTC or a combination of many factors related to
participation in YCFDTC. Had this study utilized a control group, more definitive
conclusions could have been drawn. However, given the small sample size and the
difficulty of recruiting a comparable control group, this was not a feasible option.
Focus group data was limited to the participants who attended the meetings.
Approximately 15 participants were recruited, however only ten showed up. The ten
participants who attended the focus groups may represent a group of individuals with
similar ideals and values based on their willingness to participate and follow through with
their commitment. There were also dominant participants in both focus groups. The
quotes selected may only reflect the opinions and attitudes of these few individuals rather
than the entire group. Dominant participants may have discouraged other participants
from getting involved as well, which might have resulted in an omission of other
important attitudes and opinions of TITTC.
The focus groups were conducted by two researchers from the University of
Montana. The drug court coordinator was present before and after each focus group, but
was not part of the dialogue. The presence of two individuals who are not indigenous to
the population may have discouraged participants from disclosing too much information.
The participants may not have trusted the researchers, or gave socially desirable answers
to protect themselves and the outreach workers they were evaluating. Participants of
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YCFDTC may have also worried of disclosing incriminating information which could
result in program sanctions, losing child custody, or being arrested, regardless of
confidentiality being established.

Recommendations
The population examined in this study appears to have a solid foundation for HIV
knowledge, and less of an understanding of HCV. It would be beneficial to continue to
incorporate HCV education for drug use interventions, as injection drug use is the
primary route of transmission for this virus (CDC: Hepatitis, 2008). Offering sterile
injection equipment or information on where such equipment could be obtained may also
result in a reduction in HCV transmission (Edlin, 2002) as well as encouraging safer drug
use practices should relapse occur. TITTC’s effectiveness may also benefit from
focusing more heavily on misconceptions, myths, sexual transmission and condom use
for HIV amongst this population, as injection drug transmissions rates are low and sexual
transmission remains a primary route of exposure (Booth et al., 2000). Many participants
missed questions pertaining to these topics on the pre and posttest survey as well.
It would also be advisable to increase the length and number of sessions of the
intervention to match the recommendations from Lyles et al. (2007). This would allow
additional time to incorporate more of the elements of an effective HIV intervention.
TITTC appeared to have had a greater effect on factors related to HCV rather than HIV
prevention, so lengthening the intervention and emphasizing the difference in
transmission modes between HIV and HCV may be useful for future interventions. For
example, one or two sessions could focus on HCV and intentions to abstain from drugs
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and one or two sessions could focus on HIV and intentions to practice safer sex. This
distinction might help participants understand that while HIV and HCV are both diseases
that afflict persons who use drugs, their primary modes of transmission are dramatically
different. While it is possible to transmit HCV sexually, the rate of sexual transmission is
minimal. HIV can be transmitted via injection drug use; however sexual transmission is
the primary route of infection for this virus (Booth et al., 2000). Furthermore, individuals
who take the necessary precautions to protect themselves from HCV when injecting
drugs would also ensure protection from HIV (Edlin et al., 2005; Hahn et al, 2002). This
has been seen in needle exchange programs where HIV and HCV incidences decrease
overtime (Edlin et al., 2005).

In the end, separating information base on primary modes

of transmission may reduce confusion about disease transmission and risks.
Finally, TITTC may benefit from offering on site testing to ensure all participants
know their disease status which may contribute to a reduction in disease transmission.
While this study found increases in the total number of participants tested for HCV from
pre to posttest, there was still one individual who was not tested through the three month
follow up. Individuals who test positive for HIV and/or HCV can also seek out medical
attention and counseling as needed.

Conclusions
The data collected during this research was used to determine the effectiveness of Taking
it to Treatment Court. While the small sample size limited the researchers ability to draw
definitive conclusions based on statistical tests, several findings appear to have practical
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significance for prevention specialists who work with individuals who use injection
drugs.
One of the most important finding in this study may be the dramatic difference
between participants’ gains in knowledge about HCV versus gains in knowledge about
HIV. HCV has not been the primary focus of prevention efforts targeted toward drug
users and as a result transmission and prevalence rates are alarmingly high among
persons who use injection drugs (Edlin, 2002). It is not surprising then that participants’
scores on the Hepatitis C Knowledge Questionnaire at baseline were low and that focus
group results validated participants’ lack of knowledge about HCV. The positive effects
of the intervention can be clearly seen in the two week posttest and three month followup results from this study wherein participants made significant gains in knowledge about
HCV transmission and prevention. In addition, the effects of the intervention on HCV
are reinforced by the increase number of participants who were tested for HCV from
pretest to two week posttest. Both these finding strengthens the argument by Edlin
(2002) that more emphasis needs to be placed on HCV prevention for persons who use
drugs.
On the other hand, HIV prevention has been the focus of prevention efforts in
Montana for nearly two decades (Kops, 2010) and may be the reason baseline scores on
the HIV Knowledge Questionnaire were high. Because of the high initial scores, no
increase in knowledge was found on either the two week posttest or the three month
follow-up test. This may indicate that relative to HCV less intervention time needs to be
spent on information on HIV.
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A second important finding in this study was the statistically significant increase
in intentions to abstain from drug use from pretest to two week posttest. This increase
may be, in part, a result of increased knowledge about HCV. Knowing the dangers of
HCV may have provided the participants further incentive to abstain from drugs. It is
also highly probable that increased intention to abstain from drug use was a result of the
combined effects of YFDTC’s and TITTC’s focus on abstinence from drug use. It was
not possible to separate the effects of participants’ overall involvement in the day to day
activities of drug treatment court from the effects of the six hour TITTC intervention.
However, it is likely that both programs contributed to the short term statistically
significant change in intentions to abstain from drug use.
A third important finding in this study was that intentions to practice safer sex
were not significantly changed over time. Overall, TPB Safer Sex scores were mixed
prior to the intervention indicating participants had mixed feeling about intentions to
practice safer sex and mixed attitudinal, normative, and control beliefs towards the
behavior. Despite the ambivalence of some of the survey participants about practicing
safer sex, focus groups participants reported that the outreach workers did a good job of
handing out condoms and lube and encouraging safer sex. Gains may not have been seen
because the intervention may not have been long enough to effect changes in sexual
practices.
Finally, it is important to recognize that despite the small sample size
statistically significant increases over time were found in HCV knowledge and in
intentions to abstain from drug use. Given that this intervention may have been effective
at increasing HCV knowledge, may have contributed to participants gains in intentions to
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abstain from drugs and is perceived in a positive light by individual participants, it may
be worthwhile to consider expanding it to other treatment courts where HIV/HCV
education and prevention are woefully absent and where evaluation efforts can be
expanded to include a comparison of individuals who participate in TITTC and those
who do not participate.
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THEORY OF PLANNED BEHAVIOR: ELICITATION INTERVIEWS

recovering user

current user/
intention to stop

current user/no
intention to stop

DRUG USE
Behavioral Outcomes of Drug Use
1. What do you believe are the positive aspects of drug use?
2. What do you believe are the negative aspects of drug use?
3.

Is there anything else you associate with drug use?

Normative Referents for Drug Use
1. Are there any individuals or groups who would approve of your drug use?
2. Are there any individuals or groups who would disapprove of your drug use?
3. Are there any other individuals or groups who come to mind when you think about
drug use?
Control Factors for Drug Use
1. What factors or circumstances would enable you to stop using drugs?
2. What factors or circumstances would make it difficult or impossible for you to stop
using drugs?
3. Are there any other issues that come to mind when you think about the difficulty of
not using drugs?

Practicing safer sex

Not Practicing safer sex
a

SAFER SEX
Behavioral Outcomes of Safer Sex
1. What do you feel are the advantages of safer sex, i.e. male/female condom use?
2. What do you feel are the disadvantages of safer sex?
3. Is there anything else you associate with safer sex?
Normative Referents for Safer Sex
1. Are there any groups or individuals who would approve of you having safer sex?
2. Are there any groups or individuals who would disapprove of you having safer
sex?
3. Are there any other individuals or groups who come to mind when you think
about safer sex?
Control Factors for Safer Sex
1. What factors or circumstances would enable you to practice safer sex?
2. What factors or circumstances would make it difficult or impossible to practice
safer sex?
3. Are there any other factors that come to mind when you think about the
difficulty of practicing safer sex?
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Evaluation Survey
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University of Montana
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Elizabeth Speaker, BA
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a

Taking it to Treatment Court:
Evaluation Survey
Instructions:
Please read each question
thoroughly and answer to the
best of your ability. Do not
spend much time answering each
question; generally your first
thought is the best answer.
Your identity will be completely protected and the
answers you provide will not be used against you in any
way. Absolutely do not write your name anywhere on
this survey.
If at any time you decide you are not comfortable with a
question or completing the survey please do not hesitate
to leave the question blank or stop filling out the survey.
Thank you very much. Your time is greatly appreciated!.
Code Number

Please circle the month you were born:
Jan.

Feb.

March April May June July Aug. Sept. Oct. Nov. Dec.
AND Write the first three letters of your mother’s first name: ___________

b

Section 1: Demographics
1. Age: _____ years
2.

Biological Sex (sex at birth):

Male

Female

3. What is your sexual orientation?

Heterosexual/straight
Homosexual/gay or lesbian
4.

5.

Bisexual
Unsure

What is your relationship status?
 Single
 Married
 Divorced
 Separated

 Widowed
 Living with a partner/not
married

How many children do you have?

1

2

3

4

5

6

7+

6. What is the highest level of education you have completed?

Less then high school
High school graduate/GED
Trade vocational school

Some college
College graduate
Graduate/Professional school

7. Prior to treatment had you been tested for? (circle one)

HIV:
Hepatitis C:

Yes
Yes

No
No

8. Are you employed or do you have other regular income?

Yes

No

9. Which of the following represents your individual yearly income?
(The amount you would claim on your income tax forms.)
< 6,000
6,000 - 10,000
10,001 - 20,000
20,001 – 35,000

35,001 - 50,000
50,001 - 75,000
75,001 -100,000
100,000+

c

10. With which of the following do you identify?
White (non-Hispanic)
American Indian/Alaska Native
Black/African American (non-Hispanic)
Hispanic/Latino/Chicano
Asian/Pacific American
Bi-racial or multi-racial/ethnic (Please specify) _______________
Other (Please specify) _____________________

Section 2: Drug Use and Safer Sex Survey
Sample Question
The questions in this survey use a seven point scale to rank each item. Please mark
the position on the scale you feel best fits your opinion. For example, the question
may ask you to rank the following statement:
Summer is my favorite season of year.
Agree _ 1 _ : _ 2 _ : _ 3 _ : _ 4 _ : _ 5 _ Disagree
Extremely Agree

Neither

Disagree

Extremely

If you extremely agree that summer is your favorite season, then you mark an X
where the number one would be.
Summer is my favorite season of the year
Agree _ X _ : _ _ : _ _ : _

_:_

_ Disagree

If you feel summer is neither your favorite, nor least favorite season of the year,
then you mark an X where the number four would be.
Summer is my favorite season of the year
Agree _ _ : _ _ : _ X _ : _

_:_

_ Disagree

In marking your ratings, please remember the following points:
 Be sure to answers all items
 Never supply more than one answer for any one question.
Some of the questions may appear to be asking the same thing, however they are
asking somewhat different issues. Please read the questions carefully before
marking your answer.
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Each question in the section below refers to your PAST DRUG USE
1. Drug use is a way for me to escape from my problems
Strongly agree___ ___ ___ ___ ___ Strongly disagree
2. If I stop using drugs my friendships with people who use drugs will end
Extremely likely___ ___ ___ ___ ___ Extremely unlikely
3. Drug use leads to ________ relationships with my family
Very good___ ___ ___ ___ ___ Very poor
4. I will get my kids back if I stop using drugs
Strongly agree___ ___ ___ ___ ___ Strongly disagree
5. Going to jail because of my drug use is
Extremely likely___ ___ ___ ___ ___ Extremely Unlikely
6. My health is __________ when I use drugs
Very poor___ ___ ___ ___ ___ Very good
7. I have lost touch with reality because of drug use
Strongly disagree ___ ___ ___ ___ ___ Strongly agree
8. Drugs have made it_______ for me to hold a steady job
Extremely likely ___ ___ ___ ___ ___ Extremely Unlikely
9. Overall, I think drug use is
Harmful ___
Pleasant ___
Enjoyable ___
Easy to avoid ___

___
___
___
___

___
___
___
___

___
___
___
___

___ Beneficial
___ Unpleasant
___Not enjoyable
___ Difficult to avoid

10. Using drugs increases my risk for HIV
Extremely likely ___ ___ ___ ___ ___ Extremely Unlikely
11. Using drugs increases my risk for Hepatitis C
Extremely likely ___ ___ ___ ___ ___ Extremely Unlikely
12. Escaping from my problems through drug use is
Extremely Undesirable ___ ___ ___ ___ ___ Extremely Desirable
13. Maintaining my friendships with friends who use drugs is
Extremely Undesirable ___ ___ ___ ___ ___ Extremely Desirable
14. Maintaining positive relationships with my family
Extremely Undesirable ___ ___ ___ ___ ___ Extremely Desirable
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15. Getting my kids back is
Extremely Desirable ___ ___ ___ ___ ___ Extremely Undesirable
16. Going to jail is
Extremely Undesirable ___ ___ ___ ___ ___ Extremely Desirable
17. Maintaining good health is
Extremely Undesirable ___ ___ ___ ___ ___ Extremely Desirable
18. Losing touch with reality is
Extremely desirable ___ ___ ___ ___ ___ Extremely Undesirable
19. Maintaining a steady job
Extremely Undesirable ___ ___ ___ ___ ___ Extremely Desirable
20. Decreasing my risk for/spreading of HIV by not using drugs is
Extremely Undesirable ___ ___ ___ ___ ___ Extremely Desirable
21. Decreasing my risk for/spreading of Hepatitis C by not using drugs is
Extremely Desirable ___ ___ ___ ___ ___ Extremely Undesirable
22. My using friends think that I _______________use drugs
Should ___ ___ ___ ___ ___ Should not
23. My parents and siblings think that I _______________use drugs
Should ___ ___ ___ ___ ___ Should not
24. My child/children think that I _________________use drugs
Should ___ ___ ___ ___ ___ Should not
25. The Yellowstone Family Treatment Drug Court thinks that I ________________use drugs
Should ___ ___ ___ ___ ___ Should not
26. My using friends’ opinions on my drug use are important to me
Extremely ___ ___ ___ ___ ___ Not at all
27. My parent’s and sibling’s opinions on my drug use are important to me
Extremely ___ ___ ___ ___ ___ Not at all
28. My child’s/children’s opinions on my drug use are important to me
Extremely ___ ___ ___ ___ ___ Not at all
29. The Yellowstone Family Treatment Drug Court’s opinions on my drug use are important to
me
Extremely ___ ___ ___ ___ ___ Not at all
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30. I lack the knowledge of how to stop using drugs
Strongly agree ___ ___ ___ ___ ___ Strongly disagree
31. The threat of going to jail/prison is enough to keep me from using drugs
Disagree ___ ___ ___ ___ ___ Agree
32. When I am depressed or lonely I am______________ to use drugs
Unlikely ___ ___ ___ ___ ___ Likely
33. I will have to find new friends that do not use drugs
Unlikely ___ ___ ___ ___ ___ Likely
34. Running into using friends tempts me to use again
Very much so ___ ___ ___ ___ ___ Not at all
35. When my kids are around I use drugs
Unlikely ___ ___ ___ ___ ___ Likely
36. Being around drugs tempts me to use
Strongly agree___ ___ ___ ___ ___ Strongly disagree
37. I have used drugs to cope with stress
Unlikely ___ ___ ___ ___ ___ Likely
38. I am able to find a job
Likely ___ ___ ___ ___ ___ Unlikely
39. My family relationships fell apart because of my drug use
Unlikely ___ ___ ___ ___ ___ Likely
40. Having the knowledge on how to stop using drugs would make it ________that I would
stop using
Less likely ___ ___ ___ ___ ___ More likely
41. I will not go to jail/prison because of my drug use
Agree ___ ___ ___ ___ ___ Disagree
42. I can cope with depression or loneliness without turning to drugs
Unlikely ___ ___ ___ ___ ___ Likely
43. It is _______ that I will find new friends that do not use drugs
Extremely likely___ ___ ___ ___ ___ Extremely unlikely
44. I can run into using friends and control my urges to use
Extremely likely ___ ___ ___ ___ ___ Extremely unlikely
45. It is _____________ that I will use again if I do not get my kids back
Extremely likely___ ___ ___ ___ ___ Extremely unlikely
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46. I can be around drugs and not use
Extremely likely___ ___ ___ ___ ___ Extremely unlikely
47. Feeling stressed would make it ________ that I would use drugs to cope
Extremely likely ___ ___ ___ ___ ___ Extremely unlikely
48. Having a job makes it _______ to stay off drugs
Much more difficult ___ ___ ___ ___ ___ Much easier
49. I am _________ to stay clean if my regain my relationships with my family
Less likely___ ___ ___ ___ ___ More likely
50. Changing my entire lifestyle to stay clean will be
Very undesirable ___ ___ ___ ___ ___ Very desirable
Extremely likely ___ ___ ___ ___ ___ Extremely unlikely
Beneficial ___ ___ ___ ___ ___ Harmful
Good ___ ___ ___ ___ ___ Bad

Each question in this section refers to you practicing safer sex.
Safer sex is defined as using a condom.
51. Using a condom does not feel good
Strongly agree ___ ___ ___ ___ ___ Strongly disagree
52. I will lose the trust of my partner if I decide we should use condoms
Strongly agree ___ ___ ___ ___ ___ Strongly disagree
53. Being with a partner for a long time reduces the need to use condoms
Strongly agree___ ___ ___ ___ ___ Strongly disagree
54. Using condoms reduces my risk for HIV and other Sexually Transmitted Diseases (STDs)
Strongly agree ___ ___ ___ ___ ___ Strongly disagree
55. Using condoms reduces my risk for Hepatitis C
Strongly agree ___ ___ ___ ___ ___ Strongly disagree
56. Using a condoms inconvenient
Strongly agree ___ ___ ___ ___ ___ Strongly disagree
57. Condoms are too expensive
Strongly agree ___ ___ ___ ___ ___ Strongly disagree
58. Having sex without a condom with a casual partner is too risky
Strongly agree ___ ___ ___ ___ ___ Strongly disagree
59. Having sex without a condom is _________________ sex with a condom
More desirable ___ ___ ___ ___ ___ Less desirable
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60. Maintaining the trust of my partner is _________________ than asking my partner to use
a condom
More important ___ ___ ___ ___ ___ Less important
61. It is _________________ that I will use condoms with a long time partner
Likely ___ ___ ___ ___ ___ Unlikely
62. Reducing my risk for HIV and other STDs by using a condom is
Extremely desirable ___ ___ ___ ___ ___ Extremely undesirable
63. Reducing my risk for Hepatitis C by using a condom is
Extremely desirable___ ___ ___ ___ ___ Extremely undesirable
64. The convenience of having sex without a condom is ____________ than sex with a
condom
More desirable ___ ___ ___ ___ ___ Less desirable
65. Regardless of the expense of condoms it is __________ that I will still use condoms
Very Likely ___ ___ ___ ___ ___ Very Unlikely
66. Protecting myself from STDs or pregnancy that may occur from sex without a condom
with a casual partner is:
Very Unlikely ___ ___ ___ ___ ___ Very Likely

67. My current sex partner thinks I/we __________ use condoms
Should ___ ___ ___ ___ ___ Should not
68. My friends think I ________________ use condoms
Should ___ ___ ___ ___ ___ Should not
69. Any casual sex partners I have had thought I/we _____________ use condoms
Should ___ ___ ___ ___ ___Should not
70. My sex partner’s opinions about condom use are important to me
Extremely ___ ___ ___ ___ ___ Not at all
71. My friend’s opinions about condom use are important to me
Extremely ___ ___ ___ ___ ___ Not at all
72. My casual sex partner’s opinions about condom use are important to me
Extremely ___ ___ ___ ___ ___ Not at all
73. I am confident that I could use a condom when I am not sober
Strongly agree ___ ___ ___ ___ ___ Strongly disagree
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74. The decision to use condoms is beyond my control
Strongly agree ___ ___ ___ ___ ___ Strongly disagree
75. I am confident that I could use a condom when in the heat of the moment
Strongly agree ___ ___ ___ ___ ___ Strongly disagree
76. The resources I need to practice safer sex are not available to me
Strongly agree ___ ___ ___ ___ ___ Strongly disagree
77. For me to use a condom when I am not sober is
Extremely likely___ ___ ___ ___ ___ Extremely unlikely
78. Whether or not a condom is used during sex is entirely up to me
Strongly agree ___ ___ ___ ___ ___ Strongly disagree
79. For me to use a condom when in the heat of the moment is
Extremely likely ___ ___ ___ ___ ___ Extremely Unlikely
80. If I had the resources available I would use condoms all the time
Extremely likely ___ ___ ___ ___ ___ Extremely unlikely
81. Overall, I think using a condom is
Harmful ___ ___ ___ ___ ___ Beneficial
Pleasant ___ ___ ___ ___ ___ Unpleasant
Likely for me to do ___ ___ ___ ___ ___Unlikely for me to do
Extremely Easy ___ ___ ___ ___ ___ Extremely Difficult
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Past Behavior: Self Report
82. I have been in drug treatment _____ times, excluding this time.
83. In the three months prior to entering Yellowstone County Family Drug Treatment
Court (YCFDTC) I used drugs:
 Daily
 Monthly (1-2 times/month)
 Weekly (1-2 times/week)
 Never
84. In the three months prior to entering YCFDTC I injected drugs:
 Daily
 Monthly (1-2 times/month)
 Weekly (1-2 times/week)
 Never
85. In the past three months I have used drugs:
 Daily
 Monthly (1-2 times/month)
 Weekly (1-2 times/week)
 Never
86. In the past three months I injected drugs:
 Daily
 Monthly (1-2 times/month)
 Weekly (1-2 times/week)
 Never
87. In the three months prior to entering YCFDTC I used the following drugs:

88. Prior to entering YCFDTC I was arrested ______ times.
89. During the past three months I have been arrested for the following charges:

90. I have been tested for HIV (circle one): yes
a. If yes, I was:
positive
negative
91. I have been tested for HCV (circle one): yes
a. If yes, I was:
positive
negative
92. My risk factors for HIV/Hepatitis C include:
 Injection Drug Use
 Having unprotected anal sex with men
 Having unprotected heterosexual sex
 Not a member of a risk group

no

no
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Section 3: HIV Knowledge Questionnaire
For each statement, please check True, False, or Don’t Know.
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.

If you do not know, please do not guess; instead, circle “Don’t Know.”
[ ] True [ ] False [ ] Don’t
HIV and AIDS are the same thing.
Know
[ ] True [ ] False [ ] Don’t
There is a cure for AIDS.
Know
[ ] True [ ] False [ ] Don’t
A person can get HIV from a toilet seat.
Know
[
]
True
[
]
False
[
]
Don’t
Coughing and sneezing DO NOT spread HIV.
Know
[ ] True [ ] False [ ] Don’t
HIV can be spread by mosquitoes.
Know
[ ] True [ ] False [ ] Don’t
AIDS is the cause of HIV.
Know
[ ] True [ ] False [ ] Don’t
A person can get HIV by sharing a glass of water
Know
with someone who has HIV.
[ ] True [ ] False [ ] Don’t
HIV is killed by bleach.
Know
[ ] True [ ] False [ ] Don’t
It is possible to get HIV when a person gets a
Know
tattoo.
[ ] True [ ] False [ ] Don’t
A pregnant woman with HIV can give the virus to
Know
her unborn baby.
[ ] True [ ] False [ ] Don’t
Pulling out the penis before a man climaxes/cums
Know
keeps a woman from getting HIV during sex.
[ ] True [ ] False [ ] Don’t
A woman can get HIV if she has anal sex with a
Know
man.
Showering, or washing one’s genitals/private parts, [ ] True [ ] False [ ] Don’t
Know
after sex keeps a person from getting HIV.
[ ] True [ ] False [ ] Don’t
Eating healthy foods can keep a person from
Know
getting HIV.
[
]
True
[
]
False
[
]
Don’t
All pregnant women infected with HIV will have
Know
babies born with AIDS.
[ ] True [ ] False [ ] Don’t
Using a latex condom or rubber can lower a
Know
person’s chance of getting HIV.
[
]
True
[
]
False
[
]
Don’t
A person with HIV can look and feel healthy.
Know
[ ] True [ ] False [ ] Don’t
People who have been infected with HIV quickly
Know
show serious signs of being infected.
[ ] True [ ] False [ ] Don’t
A person can be infected with HIV for 5 years or
Know
more without getting AIDS.
There is a vaccine that can stop adults from getting [ ] True [ ] False [ ] Don’t
Know
HIV.
[ ] True [ ] False [ ] Don’t
Some drugs have been made for the treatment of
Know
AIDS.
l

22. Women are always tested for HIV during their pap
smears.
23. A person cannot get HIV by having
oral sex, mouth-to-penis, with a man who has HIV.

[ ] True

[ ] False

[ ] True

[ ] False

24. A person can get HIV even if she or he has sex with
another person only one time.
25. Using a lambskin condom or rubber is the best
protection against HIV.
26. People are likely to get HIV by deep kissing, putting
their tongue in their partner’s mouth, if their
partner has HIV.
27. A person can get HIV by giving blood.

[ ] True

[ ] False

[ ] True

[ ] False

[ ] True

[ ] False

[ ] True

[ ] False

28. A woman cannot get HIV if she has sex during her
period.
29. You can usually tell if someone has HIV by looking
at them.
30. There is a female condom that can help decrease a
woman’s chance of getting HIV.
31. A natural skin condom works better against HIV
than does a latex condom.
32. A person will NOT get HIV if she or he is taking
antibiotics.
33. Having sex with more than one partner can
increase a person’s chance of being infected with
HIV.
34. Taking a test for HIV one week after having sex will
tell a person if she or he has HIV.
35. A person can get HIV by sitting in a hot tub or a
swimming pool with a person who has HIV.
36. A person can get HIV through contact with saliva,
tears, sweat, or urine.
37. A person can get HIV from a
woman’s vaginal secretions/wetness from her
vagina.

[ ] True

[ ] False

[ ] True

[ ] False

[ ] True

[ ] False

[ ] True

[ ] False

[ ] True

[ ] False

[ ] True

[ ] False

[ ] True

[ ] False

[ ] True

[ ] False

[ ] True

[ ] False

[ ] True

[ ] False

38. A person can get HIV if having oral sex, mouth on
vagina, with a woman.
39. If a person tests positive for HIV, then the test site
will have to tell all of his or her partners.
40. Using Vaseline or baby oil with condoms lowers
the chance of getting HIV.
41. Washing drug use equipment/”works” with cold
water kills HIV.

[ ] True

[ ] False

[ ] True

[ ] False

[ ] True

[ ] False

[ ] True

[ ] False

[ ] Don’t
Know
[ ] Don’t
Know
[ ] Don’t
Know
[ ] Don’t
Know
[ ] Don’t
Know
[ ] Don’t
Know
[ ] Don’t
Know
[ ] Don’t
Know
[ ] Don’t
Know
[ ] Don’t
Know
[ ] Don’t
Know
[ ] Don’t
Know
[ ] Don’t
Know
[ ] Don’t
Know
[ ] Don’t
Know
[ ] Don’t
Know

[ ] Don’t
Know
[ ] Don’t
Know
[ ] Don’t
Know
[ ] Don’t
Know
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42. A woman can get HIV if she has vaginal sex with a
man who has HIV.
43. Athletes who share needles when using steroids
can get HIV from the needles.
44. Douching after sex will keep a woman from getting
HIV.
45. Taking vitamins keeps a person from getting HIV.

[ ] True

[ ] False

[ ] True

[ ] False

[ ] True

[ ] False

[ ] True

[ ] False

46. A person cannot get HIV by having sex with a
person who is HIV+ but is taking antiretroviral drugs.
47. A person cannot get HIV from a person who is
HIV+ and has a zero viral load.

[ ] True

[ ] False

[ ] True

[ ] False

[ ] Don’t
Know
[ ] Don’t
Know
[ ] Don’t
Know
[ ] Don’t
Know
[ ] Don’t
Know
[ ] Don’t
Know

Section 4: Hepatitis C Knowledge Test
The following questions are true/false/don’t know and multiple choice.
If you do not know, please do not guess; instead, circle “Don’t Know.”

1. Hepatitis C affects which body organ?
 Heart
D. Kidneys
 Lungs
E. Don’t Know
 Liver
2. Hepatitis C is caused by ________?
 Bacteria
D. A Fungus
 A Virus
E. Don’t Know
 Alcohol
3. If I have received vaccinations for hepatitis I no longer have to worry about
Hepatitis C?
 True
B. False
C. Don’t Know
4. More people have Hepatitis C than HIV/AIDS.
 True
B. False
C. Don’t Know
5. Hepatitis C is spread by
 Blood
D. Seminal/vaginal fluid
 Saliva
E. Don’t Know
 Eating contaminated food/water
6. What is the most common way of getting Hepatitis C today?
 Sexual Activity
D. Eating contaminated
food/water
 Blood Transfusions
E. Don’t Know
 Injection Drug Use
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7. When having sex with someone who has Hepatitis C, you should ________.
 Always wear a condom
 Wear a condom if an STD or cut is present
 Never wear a condom
 Sometimes wear a condom
 Don’t Know
8. What percentage of individuals with Hepatitis C will develop chronic health
conditions?
 10-15%
D. 80-85%
 30-35%
E. Don’t Know
 60-65%
9. What is the most common symptom of chronic Hepatitis C?
 Fatigue
D. Flu-like symptoms
 Insomnia
E. Don’t Know
 High blood pressure
10. What is the most common symptom of acute Hepatitis C?
 Fatigue
D. Flu-like symptoms
 Insomnia
E. Don’t Know
 High blood pressure
11. If I am diagnosed with Hepatitis C but have no symptoms I do not need to seek
medical attention until symptoms develop?
 True
B. False
C. Don’t Know
12. Hepatitis C can cause _______.
 Heart Attack
D. High blood pressure
 Stroke
E. Don’t Know
 Cirrhosis of the liver
13. Antibiotics can treat Hepatitis C?
 True
B. False
C. Don’t Know
14. Is there a risk of transmitting Hepatitis C from an infected mother to an unborn
child?
 No risk
 Yes, a potential risk exists
 Yes, if the mother had Hepatitis C before she was pregnant
 No, if she got Hepatitis C while she was pregnant
 Don’t Know
15. How long does it usually take before chronic signs or symptoms appear after
Hepatitis C infection?
 Within the first year
D. Hepatitis C has no
symptom
 5-10 years
E. Don’t Know
 20-30 years
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16. Hepatitis C is not always life threatening?
 True
B. False
C. Don’t Know
17. How many people in the US are estimated to have Hepatitis C?
 100,000
D. 4 million
 500,000
E. Don’t Know
 1.5 million
18. If I received a blood transfusion before 1992 I am at risk for Hepatitis C?
 True
B. False
C. Don’t know
19. I am at risk for Hepatitis C when I use drugs that I do not inject?
 True
B. False
C. Don’t Know
20. Hepatitis C can remain active and contagious for up to four days outside the
body?
 True
B. False
C. Don’t Know
21. How can you determine whether or not you have Hepatitis C?
 Tired all the time
D. Urine Test
 Constant abdominal pain
E. Don’t Know
 Blood Test
22. Touching or using the bathroom after someone with Hepatitis C puts me at risk
for Hepatitis C?
 True
B. False
C. Don’t know

Thank you again for your time!!!
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Appendix C
Yellowstone County Family Drug Treatment Court:
Participant Criteria
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13th Judicial District
Yellowstone County Family Drug Treatment Court
Participation Criteria

The court is targeting parents whose children have been placed into the child welfare
system due to abuse and/or neglect related to substance abuse, using the listed criteria to
determine eligibility.
Client must meet the following criteria to be considered for participation in YCFDTC:









Parent is 18 years of age or older
Parent has neglected/abandoned child and there are allegations of substance abuse
The child has been removed and the parent(s) acknowledges the removal is due to
substance abuse-related neglect
Parent meets DSM-IV criteria for drug/alcohol dependence
Parent is able to understand and willing to comply with Participation Agreement and
Informed Consent
Parent is willing to participate in Yellowstone County Family Drug Treatment Court
Child(ren) have been adjudicated as youth in need of care and temporary legal custody
has been granted to DPHHS-Child and Family Services Division
Treatment team approval

If client meets one or more of the following criteria, client will be ineligible for
participation in YCFDTC:






Parent is not a resident of Yellowstone County, Montana
Parent has been convicted of a deliberate homicide or murder, kidnapping, robbery,
felony assault or other violent felonies, sex offenses
Parent has another charge pending for which (s)he would be deemed ineligible
Parent has a medical or psychiatric condition causing a degree of impairment or
instability such that it would interfere with program participation and functioning
Parent can not effectively participate in YCFDTC because of time constraints imposed by
the Adoptions and Safe Families Act
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Appendix D
Focus Group Questions
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Focus Group Questions
1. What do you recall about the HIV/HCV program?
2. What effect, if any, did the program have on you while you were going through
treatment court?
3. More specifically, what effect did your participation in the program have on the
following:
a. Your knowledge about how to prevent HIV
b. Your knowledge about how to prevent HCV
c. Your attitude about abstaining from drug use
d. Your attitude about using condoms
e. Your sense of support for abstaining from drug use from significant
people in your life
f. Your sense of support for using condoms from significant people in your
life
g. Your level of confidence that you will be able to abstain from drug use
h. Your level of confidence that you will be able negotiate the use of
condoms with your sexual partners
4. What suggestions do you have for improving future HIV/HCV prevention
programs?
5. Do you have any additional comments that you would like to add about the
program or anything else we’ve discussed?
6. If you were to choose one thing that was most memorable or most helpful about
the program, what would it be?
7. How effective do you think the program would be if it were taught by someone
other than Casey and Eddie?
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Appendix E
Cover Letter to Participants
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Dear Taking it to Treatment Court Participant,
My name is Casey Rudd and I’ll be facilitating a program you will
be attending called, “Taking it to Treatment Court.” The state
public health department wants to conduct an evaluation study of
the program to see if it makes a difference in the lives of people
who participate. Therefore, we are asking you to complete the
questionnaire enclosed in this packet.
Enclosed you will find the Taking it to Treatment Court Evaluation
Survey along with $10 for completing the survey. A self addressed
stamped envelope is also provided for you to mail your responses
directly to the researchers at the University of Montana. Again, all
your answers will remain anonymous, and your identity will not be
disclosed to the researchers at the University of Montana or facility
of the Yellowstone County Family Drug Treatment Court. You
can also participant in a focus group that will be held after Taking
it to Treatment Court has ended. Upon participation you will
receive $20?

Thank You,

Casey Rudd
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Institutional Review Board Approval

104

5.
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